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ABSTRACT 
Eva Katz:  The association of body weight and circumferences with metabolic risk factors in 
Chinese men and women 
(Under the direction of June Stevens, PhD) 
 
One nation facing a dramatic rise in the prevalence of adult overweight and obesity is 
China, where rates have increased approximately 400% in the past 20 years.  This research 
examined issues related to the risks of adiposity in Chinese men and women including the 
associations between body mass index (BMI) and incident hypertension compared to 
American Blacks and American Whites; the interaction between BMI, age and parental 
history of hypertension on hypertension prevalence; and finally the influence of hip 
circumference on the components of the metabolic syndrome. 
Data were from Chinese Asian, American Black and American White men and 
women from three prospective, observational studies of the natural history and risk factors 
for cardiovascular disease.  Chinese Asians (young and middle-aged adults) were from the 
People’s Republic of China (PRC) study, American Black and American White young adults 
were from the Coronary Artery Risk Development in Young Adults (CARDIA) study and 
American Black and American White middle-aged adults were from the Atherosclerosis Risk 
in Communities (ARIC) study.  Our goal was to predict risk differences and since binomial 
and Poisson models did not converge, we fit logistic regression models and calculated the 
adjusted standardized estimates using the “prvalue” command in Stata (Version 10.0).   
The effects of BMI on hypertension incidence were stronger in Chinese Asians 
compared to American Blacks and Whites; effect modification of the BMI-hypertension 
iv 
relationship by age and parental history of hypertension status was detected; and despite the 
relative leanness of the Chinese population, a larger hip circumference was associated with a 
lower risk of incident metabolic risk factors when controlling for overall adiposity.  These 
data expand on our understanding of the impact of elevated body weight and a larger hip 
circumference in a Chinese population.  
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 I. INTRODUCTION 
A. Background 
Over the past few decades, the prevalence of overweight and obesity has increased 
globally.  One nation facing a dramatic rise in weight status is China.  Along with global 
expansion and economic development, overweight and obesity have increased approximately 
400% over the past 20 years among Chinese adults.1  This dissertation research will examine 
several issues related to the risks of obesity in Chinese men and women.  Specifically, it will 
focus on the associations between body mass index (BMI) and hypertension, the interaction 
between BMI, age and parental history of hypertension and finally the effect of hip 
circumference on the components of the metabolic syndrome. 
Numerous studies have shown an increase in hypertension and other metabolic risk 
factors with increasing BMI.  The level of risk at a specific level of obesity often varies by 
ethnicity.  Epidemiologic studies on Chinese populations have observed an increase in 
metabolic risk factors at a BMI of 21-24 kg/m2, values considered normal by the World 
Health Organizations (WHO) standards (>18.5 to <25 kg/m2).2-5  Based on this literature a 
BMI of 23 or 24 kg/m2 is commonly suggested to be a more meaningful cutpoint to define 
overweight within China.  However, much of the research in support of lower BMI cutpoints 
lacks a Caucasian or non-Asian comparison group.  
The risk conferred by excess adiposity may be modified by genetic factors as well as 
age.  Parental history of disease is commonly collected as a marker of heritability of 
hypertension in clinical and epidemiological studies.  Risk scores to predict incident 
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hypertension in Caucasian populations 6 incorporate measures of adiposity, parental history 
of hypertension and age as strong predictors in the risk score calculation.  Better 
understanding of the interaction of parental history of hypertension, adiposity and age on 
hypertension risk in non-Caucasian populations may help identify individuals who present 
with greater disease risk and target them for disease prevention efforts.  
In addition to overall adiposity, regional depots of adiposity are associated with 
hypertension and metabolic risk.  Although greater levels of abdominal adiposity have been 
shown to be deleterious, adiposity in the gluteo-femoral or hip region has been shown in 
some cohorts to exert a protective effect.  A limited body of research has examined the 
independent effect of hip circumference on cardiovascular risk factors.7-10  These studies 
have been conducted almost exclusively in Caucasian populations.  Therefore, it is uncertain 
if regional depots of fat exert similar effects in Chinese Asian populations. 
Data were from the following three cohorts:  
1) The Coronary Artery Risk Development in Young Adults (CARDIA) study of 
American White and American Black young adults; 2) The Atherosclerosis Risk in 
Communities (ARIC) study of American White and American Black middle-aged adults; 3) 
The People’s Republic of China (PRC) study of Chinese Asian Adults. 
B. Research aims 
The aims of this research were as follows. 
1.  Primary Aim – Determine and compare the relationship of BMI with 
hypertension among American White, American Black and Chinese Asian adults in 
early and middle adulthood. 
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1.a. Determine the ethnic specific relationship of BMI with prevalent hypertension 
among American White, American Black and Chinese Asian young (24-39 years) and 
middle-aged (45-64 years) adults.  
1.b. Determine the ethnic specific relationship of BMI with incident hypertension 
among American White, American Black and Chinese Asian young (24-39 years) and 
middle-aged (45-64 years) adults. 
 
2.  Secondary Aim – Determine the influence of parental history of hypertension 
on the relationship of BMI with prevalent hypertension in Chinese Asian adults; 
examine if this relationship differs by age.  
 
3.  Tertiary Aim – Determine the independent association of hip circumference 
(HC) with incident metabolic risk factors in Chinese Asian adults aged 24-71, over 
approximately six years of follow-up; and determine if the relationship differs by age.  
 
 
 II. LITERATURE REVIEW 
A. Obesity in Asians 
1. Overview 
BMI provides a reliable indicator of body fatness.  Therefore, the National Institutes 
of Health and the World Health Organization use BMI, (weight (kg) / height (m2)), as a 
criterion measure to define underweight (<18.5 kg/m2), normal weight (18.5 to <25.0 kg/m2), 
overweight (25.0 to <30.0 kg/m2) and obesity (>30 kg/m2).  Both epidemiological and 
randomized clinical trials have established excess adiposity to be associated with greater 
risks of morbidity.  The overweight and obese categories are believed to confer the greatest 
health risks among most populations. 
The prevalence of adult overweight and obesity continues to increase among adults in 
both China and the United States (U.S.). Within China, the prevalence of adults who fall 
above the overweight and obesity cutpoint is 24% and 4%, respectively, indicating 
approximately one in four Chinese adults are overweight or obese.11  Compared to China, the 
proportion of overweight and obese adults in the United States is much higher, as the 
majority of adults are classified above the ‘normal weight’ category. The proportion of adults 
who fall above the overweight and obese cutpoints are 66% and 32%, respectively.12  When 
examining the obesity prevalence by ethnicity, the African American community experiences 
the greatest burden of obesity (45%), an absolute greater prevalence of 13% compared to the 
U.S. national average.   
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2. BMI cutpoints rationale 
The WHO’s most recent consensus statement, issued in 2004, suggested a range of 
plausible BMI cutpoints for overweight and obese exist for Asians, depending on the 
outcome of interest.13   Based on the existing scientific evidence and expert consensus, China 
responded by establishing country specific standards to define overweight (24.0 kg/m2 to <28 
kg/m2) and obesity (>28 kg/m2). 
The two primary reasons most often cited in support of lower BMI cutpoints to define 
overweight and obesity in Asians are (1) evidence of greater percent body fat at the same 
BMI compared to Caucasians, and (2) an observed increase in disease risk within the normal 
BMI range.13   The Chinese adult population is one of the largest in the world, close to 1 
billion. Therefore, the elevated risk of cardiovascular related risk factors near the mean adult 
BMI (23 -24 kg/m2) results in a substantial population risk.  The excess risk of hypertension, 
diabetes and cardiovascular risk factors among Chinese at low BMI values, taken within the 
context of the population distribution of BMI, have been cited as in support for lowering 
cutpoints in China.   
3. Ethnic differences in body composition 
Ethnic differences in body composition may contribute to ethnic variations in disease 
risk associated with excess adiposity.  Deurenberg et al., 2002, reported the relationship of 
percent body fat and BMI is ethnic-specific based on differences in trunk to leg length ratio, 
slenderness and muscularity as well as other physical differences.14  For example, Chinese 
men and women are usually taller and lighter with smaller waist and hip circumference then 
other Asian nationalities.15, 16  
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Differences in body composition are not unique to Asian populations.  Ethnic 
differences in body composition between Asian and non-Asian ethnic groups have been well 
documented.14  Compared to Caucasians of the same BMI, age and gender, Asians typically 
have a 3-5% higher body fat.  Likewise, for the same body fat percent, Asians have a BMI 3-
4 units lower than that observed in Caucasians.14, 17   
Differences in body composition have also been observed between Caucasians and 
African Americans.  African Americans have a greater bone mineral density and body 
protein content than do Caucasians, resulting in a greater fat-free body mass.  Additionally, 
there are racial differences in the distribution of subcutaneous fat and the length of the limbs 
relative to the trunk.  Generally, compared to White Americans, Black Americans have more 
subcutaneous fat in the trunk and less subcutaneous fat in the extremities.18  In addition, 
Black Americans have less visceral adipose tissue than Caucasians at the same BMI.19, 20   
Therefore, at the same BMI, Blacks tend to have greater lean body mass and less fat 
mass and visceral fat than Caucasians.  Asians have greater adiposity and a greater tendency 
towards central or truncal obesity, at the same BMI compared to Caucasians.  Since adiposity 
or some aspect of its metabolism predisposes individuals to hypertension, type 2 diabetes and 
other cardiovascular risk factors, the logical expectation is that populations with greater 
adiposity at the same BMI would have a greater prevalence of obesity related disease at each 
BMI value of overweight on CHD are understood to occur at least partly through several 
physiologic risk factors 
4. Gender differences in body composition 
Sexual dimorphism in body shape refers to the characteristically different body 
shapes between men and women.  Typically, women exhibit a gynoid shape and males an 
7 
android shape.  These characteristic shapes are hormonally driven and immerge during 
sexual maturation.  Women tend to have a greater percent body fat compared to males at the 
same BMI.  During menopause, it has been suggested that women are more prone to 
deposition of fat in the visceral or inter-abdominal region.21  Sexual dimorphism in body 
shape becomes less pronounced during this period.  Most studies have attributed these gains 
in abdominal fat to aging and not a loss of estrogen.22  However, a recent longitudinal study 
has found effects of ovarian aging, a marker for menopause, to be associated with increased 
deposition of fat in the midsection.23  
5. Body composition and fat distribution with age 
Typically, both males and females experience weight gain during adulthood up 
through ages 40–70 years, followed by decline in fat mass after age 70.24   Both gains in BMI 
and specific regions of body fat have been observed.  Waist circumference has been shown to 
increase with age even when BMI remains stable.25, 26  During young adulthood, deposition 
of fat in subcutaneous regions is more common.  However, beginning around middle 
adulthood, there is a redistribution of fat.  Subcutaneous depots decline, visceral fat is 
preserved and fat gain is typically deposited in the inter-abdominal region.24  Height and 
bone density are often lost during later adulthood.27  Physical activity during adulthood has 
been shown to protect against fat gain and muscle loss.27   
6. Risk of metabolic abnormalities within the normal BMI range 
Studies in China have shown that the risk of hypertension, diabetes and other 
cardiovascular related metabolic risk factor increases with increasing BMI.2-4, 28  The increase 
in metabolic risk factors is observed at BMI values considered normal by WHO standards 
(>18.5 kg/m2 to <25 kg/m2).  These studies, which typically lack a Caucasian comparison 
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group, have concluded a BMI of 23-24 kg/m2 may be a better cutpoint to define overweight 
within China.  This research presumes that a subsequent increase in metabolic risk factors 
within the same BMI range would not be observed within Caucasian or Western populations.  
However, research from the primarily Caucasian Nurses’ Health Study 29  and the Physician 
Follow-up study 30 suggest that the age-adjusted relative risk of diabetes increases above 1 
beginning at a BMI of 22 kg/m2 for women and 24 kg/m2 for men (within the normal BMI 
range). 
Typical analytical methods to assess the relationship of anthropometrics with adverse 
outcomes in Asians use receiver operating characteristic (ROC) curves or logistic regression 
methods.  ROC curves are highly influenced by the underlying distribution of BMI within the 
population.  The mean adult BMI is 23 kg/m2 in China, much lower than that in the United 
States.  Although the absolute risk in Chinese and other ethnic groups at a specific BMI may 
be very similar, because the BMI distribution of Chinese is shifted to the left of most 
Western populations, it is more probable that a lower country specific BMI cutpoint will 
have greater maximal sensitivity and specificity than the WHO recommended value based on 
the underlying distribution ROC analyses.  Risk estimates from logistic regression analyses, 
another common methodologic technique, use ratios that are heavily influenced by the in the 
reference range.  When the risk in the referent group differs between groups it is difficult to 
compare estimates. 
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B. Hypertension 
1.  Overview 
Although hypertension is defined by a blood pressure threshold, both systolic and 
diastolic blood pressures are associated with a continuous and graded increase in 
cardiovascular disease (CVD) events, even within the normal blood pressure range.  
Alterations in either systolic or diastolic pressure alter the circulatory system and increase the 
risk of cardiovascular morbidity and mortality.  The presence of hypertension is associated 
with a doubling of cardiovascular disease risk.  
Hypertension is prevalent throughout the world.  It has been suggested that mutations 
that produced alleles associated with hypertension occurred early in evolution and therefore, 
much of the gene—related variation in the prevalence of hypertension between populations is 
a result of differences in the prevalence of those alleles, as opposed to the action of 
completely novel variants.  Hypertension is usually observed in post-reproductive years 
allowing the genetic aspect of the disease to persist in populations.  The exceptions are 
monogenic forms – which cause a defect in blood pressure regulation that would be apparent 
at a young age. 
Using the standard definition of 140/90 mmHg or antihypertensive medication use, 
the prevalence of hypertension among the US population has increased 18%, from 24.4% in 
1988-94 to 28.9% in 1999-2004.31   The rate of awareness is 75.7%, treatment is 65.1% and 
control is 36.8%.32   Based on NHANES 1999-2004 data, Non-Hispanic Blacks have a 
greater burden of hypertension compared to Non-Hispanic Whites, 40.1% and 27.4% 
respectively.  However, estimates of awareness, treatment and control are similar.32     
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Geographic patterns in elevated blood pressure have been noted.33   Hypertension 
prevalence is higher in the southeast than in other regions of the U.S.32  Contributors to this 
pattern include geographic patterns in obesity, physical inactivity, and salt and nutritional 
intake, but not different in treatment or control of hypertension.34  Among hypertension 
patients, the level of systolic blood pressure and the prevalence of severe hypertension is also 
higher in the South.  No differences in frequency of “adding salt at the table” have been 
observed in North vs. South but the South has the highest overall sodium consumption and 
the lowest phosphorus, magnesium, copper, riboflavin, niacin, iron, and Vitamins A, C and 
B6.  Over the past 3-4 decades there have been dramatic improvements in hypertension 
awareness and treatment.  However, racial disparities still exist.  Compared to Whites, Black 
participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) 
study were more aware of their hypertension and more likely to be on treatment when aware 
but less likely to have their blood pressure controlled.35  Confounding in geography and race 
is well established.36  
Hypertension has become increasingly prevalent in developing Asian populations.  In 
China, 19% of the adult population (18 years of age and older) are hypertensive.37  Regional 
differences in the prevalence of hypertension within China have been observed.38, 39  
Hypertension is less common in southern China, where diet and exercise patterns are 
substantially different from the north.  In addition, the prevalence of hypertension is lower in 
rural than urban areas, which has been suggested to be related to higher levels of physical 
activity and lower levels of overweight.   
Among Chinese adults aged 35-74 hypertension prevalence is 27.2% and rates of 
awareness (44.7%), treatment (28.2%) and control (8.1%) are low.40  A proportion of 
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individuals use herbal or non-traditional remedies to treat blood pressure elevations.41  
Immigration of Chinese to the U.S. is associated with greater risk of hypertension.  The adult 
prevalence of hypertension among Chinese Americans is 39%, which is comparable to 
Whites.  After adjustment for BMI, age, sex, WC, alcohol, tobacco, diabetes, education, 
income and financial strain, the odds of hypertension were greater in Chinese than Whites.42, 
43
  This suggests a potential for a rapid increase in hypertension prevalence in China as diet 
and physical activity patterns transition towards those observed in the U.S.  
2.  Risk factors 
a. Genetics: 
Typically, hypertension is a multi-genic disease in which multiple genes influence the 
observed phenotype.44   Each gene has a small effect on blood pressure and environmental 
factors are necessary for the development of essential hypertension.45  In addition, there is 
genetic heterogeneity in which hypertension may be phyenotypically similar in different 
individuals but may be the result of a different combination of genes and environmental 
factors.  Genes which encode proteins involved in the function of the kidneys, heart, brain 
and vascular system are some of the genes which may be related to blood pressure regulation.  
Chromosomal regions which may be involved in hypertension phenotypes have been 
identified in meta-analyses.  Monogenic or single-gene forms of human hypertension are 
rare. These forms may be a result of mutations that result in overproduction of 
mineralcorticoids, or increased mineralcorticoid activity, alteration of renal ion transporters 
or suppression of plasma-renin activity.46  These forms would be apparent at birth. 
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b. Age: 
 Blood pressure levels and hypertension prevalence increase with age in both men and 
women as shown in Table 2.1.32  There is a gradual shift in the blood pressure risk 
relationship from increased diastolic pressure among young adults to increased systolic blood 
pressure among middle and older aged adults.47  An increase in vascular stiffness which 
occurs with aging contributes to the age-associated increase in blood pressure.48  Greater 
increase in hypertension incidence has been observed in women after age 60.49 
c. Obesity 
 Obesity, especially central adiposity, is strongly associated with chronic hypertension. 
The impact of obesity on hypertension is complex, multi-factoral and not completely 
understood.  Hemodynamic (increased blood volume), metabolic (increased sympathetic 
nervous and rennin-angiotensin activity), endocrine (altered leptin and adipokine release) 
mechanisms and structural changes (pressure on the kidneys) may lead to obesity related 
hypertension. 50, 51  
d. Gender 
 Men have higher systolic blood pressure levels than women during early and middle 
adulthood.  After age 60, women tend to have higher systolic blood pressure and greater 
hypertension incidence.  Data from NHANES 2003 – 2004 reported hypertension awareness 
and treatment were similar among men and women.32 
e. Race 
 The prevalence of hypertension varies by race in the U.S.  The age adjusted 
hypertension prevalence among adults is highest among Blacks (39.1%) compared to non-
Hispanic Whites (28.5%) based on NHANES 2003-2004.32  Examples of hypertension 
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prevalence from the U.S. based Multi-Ethnic Study of Atherosclerosis (MESA) are listed in 
Table 2.2.43  This study also found Black Americans to have the greatest prevalence of 
hypertension compared to White and Chinese Americans.  However, there is heterogeneity of 
hypertension prevalence within ethnic groups depending on the country of residence.  Blacks 
in the U.S. have a high prevalence of hypertension at all ages but this trend is not observed 
among African and Caribbean Blacks.  The age-adjusted prevalence of hypertension is low in 
rural Nigeria (13.5%) and intermediate among Blacks residing in Jamaica (28.6%), compared 
to U.S. Blacks (44.0%) .52  Heterogeneity in hypertension rates among Caucasians has also 
been observed.  There is a trend towards greater levels of hypertension among Caucasians 
residing in European countries (38.4% to 55.3%) compared to those in the U.S (26.8%).43, 52  
f. Physical Activity 
Physical activity is protective against the development and progression of 
hypertension.  Exercise is an effective means to maintain a healthy body weight.  Even in the 
absence of weight loss, exercise has shown to be an effective method to reduce blood 
pressure.53  Regular exercise improves the aging-induced increase in arterial stiffness which 
can raise blood pressure.54  Other possible mechanisms include reduction in norepinephrine 
levels 55 and increased endothelial nitric oxide release.56  However, not all individuals 
respond to the effects of physical activity to the same extent.54  
g. Diet 
Dietary modification with and without concurrent weight loss have been shown to 
have beneficial effects on blood pressure.  Many trials, including The Dietary Approaches to 
Stop Hypertension (DASH) trial, lend support to the association of blood pressure with 
specific foods and nutrients.57-62  Dietary factors such as high sodium and alcohol and low 
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potassium are associated with elevated blood pressure.61, 63  The amount, rather than type of 
alcohol is the main determinint of blood pressure levels.  Average daily intake above 
moderate levels (>1 drink for women and >2 drinks for men) is associated with raised blood 
pressure.64  Alcohol has immediate effects on vasodilation and may exert effects through 
neurohormonal sympathetic pathways, (rennin-angiotensin_aldosterone, insulin , cortisol) 
inhibition of nitric oxide, depeletion of calcium and magnesium, alteration of electrolyte 
levels and increases in acetylaldehyde.  Recommendations for lowering blood pressure 
include a diet that is reduced in saturated fat and cholesterol as well as alcohol, and one that 
emphasizes fruits, vegetables and low-fat dairy products, dietary and soluble fiber, whole 
grains and protein from plant sources. 
h. Smoking 
Cigarette smoking causes acute blood pressure elevation.65  Studies have shown 
smoking exerts effects on blood pressure via increases in arterial stiffness and increases 
arterial wave reflection, which leads to increased aortic systolic blood pressure.66  
Epidemiologic studies have found long term smoking to be associated with lower blood 
pressure levels.65  These differences in blood pressure levels between smokers and non-
smokers may be related to differences in body mass index. 
3. BMI-Hypertension relationship 
Studies in China and the United States have shown increasing prevalence and 
incidence of hypertension associated with an increase in BMI.  However, few studies have 
examined the association in both Chinese and Caucasian populations and even fewer have 
studied the relationship in Chinese, Caucasian and African American populations.   
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The majority of analyses are cross-sectional in design which limits the ability to 
disentangle causation from association.  Many potential confounders including diet, physical 
activity, smoking, drinking and education are not controlled in the analyses.  Consistently, 
researchers conclude the association of BMI with hypertension is stronger in Chinese 
compared to Caucasians.  Bell et al.67 compared the adjusted prevalence and odds of 
hypertension in 30–65 year old adults from the China Health and Nutrition Survey and 
NHANES III.  Authors acknowledge, the analysis of the odds is complicated by the 
differences in prevalence within the reference range between ethnic groups.  Lower odds at 
the reference value for the Chinese group enhances the potential odds of hypertension at 
other values.  In addition, higher prevalence estimates for Blacks diminishes the potential 
odds of hypertension.  Among men, the age-adjusted odds of hypertension was significantly 
greater in the Chinese, at BMI values in the upper normal, overweight and obese categories 
(referent range of 18.5 -22.9 kg/m2), compared to American Whites from NHANES III. 
Values for non-Hispanic Black men were not different from non-Hispanic White men at most 
BMI values.  However, the age adjusted prevalence of hypertension was highest among 
Black men within the normal BMI range and the slope was steepest among Chinese men.  
Among women, the odds of hypertension were similar within the normal BMI range and for 
most values overall.  However, the odds of hypertension was significantly lower for non-
Hispanic Black Women compared to Whites within the BMI range of 23-24.9 kg/m2 and 25 – 
26.9 kg/m2 and >31 kg/m2.  
Pan et al.68 also compared NHANES III to an Asian population, the Nutrition and 
Health Survey in Taiwan.  Similar to the Bell’s results, the age and sex standardized 
prevalence of hypertension was steeper across BMI in the Taiwanese compared to Blacks 
16 
and Whites and the adjusted prevalence was higher in Taiwanese compared to Whites.  
However, at BMI values considered normal and underweight, Black Americans had higher 
(not necessarily significant) adjusted prevalence values compared to both Whites and 
Taiwanese.  The odds ratio (95% CI) per unit change in BMI was highest in Taiwanese (1.24 
(14.11, 1.39)) compared to both U.S. Whites (1.11 (1.09,1.14)) and Blacks (1.07 (1.05, 1.09)) 
and significantly different than Blacks.  BMI cutoffs which maximize sensitivity and 
specificity in predicting hypertension were between 23.3 and 23.7 kg/m2 for Taiwanese 
males and females and between 25.6 and 28.2 kg/m2 for U.S. White and Black males and 
females. 
More recent studies have employed novel approaches. Razak69 used proportional 
hazard analyses and the Obesity in Asia collaborative (OAC) 70 conducted a meta-analysis.  
The OAC was established in 2002 to address the relationship of anthropometric measures 
with Cardiovascular risk factors in Asian compared to Caucasian populations by combining 
existing data sources from the Asia.  Results from the meta-analysis did support a greater risk 
of hypertension and other CVD related risk factors in Asians compared to Caucasian 
populations.  However, Asians within China, Hong Kong, India, Korea, Japan, Singapore, 
Thailand, and Taiwan were collectively compared to Caucasians within Australia and Iran.  
Deurenberg et al. 14 noted that there is much (genetic and environmental) heterogeneity in 
body composition within Asian populations.  Additionally, environmental and cultural 
factors are quite distinct between regions.  The effect of excess adiposity on blood pressure 
was assessed by examining the increase in systolic blood pressure (SBP), diastolic blood 
pressure (DBP) or the odds of hypertension associated with a cohort specific 0.5 SD change 
in each anthropometric (BMI, WC, WHR, WHtR).  Because a 0.5 SD change may 
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encompass a very different value and range across populations, it is difficult to interpret the 
meaningfulness of the results. 
Razak et al., 2005 & 2007 analyzed cross-sectional data on Chinese and Caucasian 
Canadian populations from the Study of Health Assessment and Risk in Ethnic groups 
(SHARE) cohort in Canada.69, 71  All subjects resided in Canada for a minimum of 5 years 
prior to data collection.  The 2005 study found an increase in median systolic pressure with 
increasing age and sex adjusted BMI quintile in both Caucasian and Chinese population.  The 
increase was steeper in the Chinese compared to Europeans.71  The 2007 study employed 
proportional hazard analyses.69  The relationship between the blood pressure factor, which 
was composed of systolic and diastolic blood pressure, at a BMI of 30 in Europeans, 
corresponded to a BMI of 25.3kg/m2 in Chinese.  The relationship between BMI and blood 
pressure factor was positive for both Chinese and Europeans. 
4. Family history of hypertension 
Hypertension and blood pressure levels aggregate in families.72, 73  It has consistently 
been reported that offspring of hypertensive individuals have a greater risk of hypertension 
than the general population.74-77  The risk increases when both parents are hypertensive.75, 76, 
78, 79
  For example, compared to subjects who had a negative family history of hypertension, 
males and females in the Monitoring Trends and Determinants in Cardiovascular Disease 
(MONICA) 75 cohort who reported only one parent with a positive parental history of 
hypertensive had a relative risk of hypertension of 2.8 and 2.0, respectively.  Within this 
same cohort, the relative risk of hypertension for subjects reporting a positive parental history 
of hypertension in both parents was 7.8 and 5.3, among males and females, respectively.  The 
gender-specific risk of hypertension was more than double among subjects with two parents 
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with a positive parental history of hypertension compared to subjects with just one parent 
with a positive parental history of hypertension. 
The strength of association between family history and incidence of hypertension is 
dependent on the age of onset of hypertension in the family member and the age of the 
individual at risk for hypertension.  A history of hypertension before age 60 invokes a greater 
risk of hypertension in offspring.75, 78  A positive parental history of hypertension among 
adults 70 years or older, is associated with no greater risk than that of the general population.  
The mean BMI among offspring with a positive parental history of hypertension is typically 
higher by approximately 0.5 or more BMI units compared to individuals with a negative 
parental history of hypertension.77, 80, 81    
Family history of hypertension is a simple and commonly used clinical index of 
familial aggregation of high blood pressure which reflects the heritability of hypertension.6  
Family aggregation of blood pressure reflects both the shared genetic information within a 
family and the shared family environment.  Multiple interactions among genes and 
environments contribute to the prevalence of hypertension such that numerous physiologic, 
biochemical and environmental factors contribute to increase blood pressure.  Therefore, 
there are many ways to become hypertensive.  Studies have shown the impact of parental 
blood pressure is evident among offspring at an early age as well as in adulthood when 
environments may no longer be shared. It is estimated that between 30% to 60% of the 
interindividual variation in blood pressure is attributed to genetic factors.82, 83  Circulating 
levels of select biomarkers, including C-reactive protein, have been shown to be higher in 
normotensive offspring with a positive parental history of disease. This suggests biological 
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effects including inflammation may mediate the effects of blood pressure on hypertension 
risk.84  
The increased risk of hypertension associated with a positive family history remains 
after adjustment for BMI.75, 80, 81, 85   However, to our knowledge, no studies have examined 
the association of adiposity with incident or prevalent hypertension according to parental 
history of hypertension status.  It is unknown whether individuals with a positive parental 
history may be more sensitive or resistant to the effects of excess weight.  
5. Hip-hypertension (or chronic disease) 
Waist to hip ratio (WHR) is fairly common anthropometric index employed in 
epidemiologic studies.  Although the measure may capture aspects of body shape that are 
undetected by BMI, it does not differentiate the independent effects of hip or waist 
circumference.  In comparison to a large waist circumference (WC), a large hip 
circumference (HC) has been suggested to be less deleterious and potentially protective.  
Each measure reflects different depots of adiposity with potentially different lipolytic 
activity.  WC reflects both visceral and subcutaneous adiposity around the abdomen, a more 
metabolically active region.  HC reflects adipose and muscle mass in the thigh and buttock 
region (gluteofemoral).  The adipose in this glutiofemoral region has been termed a “fat sink” 
because it may serve an important role in the removal of non-esterified fatty acids (NEFA) 
from the circulation.86  This hypothesized pathophysiology would protect the liver, pancreas 
and skeletal muscle from exposure and accumulation of NEFA and thereby limit the 
development of insulin resistance.  Research has shown, when mutually adjusted for one 
another and for BMI, WC and HC have independent and opposite associations with 
cardiovascular risk factors.8, 87-89 
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Limited epidemiologic evidence examines the independent effects of hip 
circumference on coronary heart disease, cardiovascular disease, cardiovascular related risk 
factors and total mortality.7-9, 87-90  These studies have employed different methodologies to 
demonstrate a larger hip circumference is associated with lower mortality and more favorable 
lipid and glucose profiles in both men and women.  Dixon, et al.,91 used ROC curves to 
identify cutoff values for hip and waist circumferences in an obese female population.  Based 
on the values generated from the ROC analysis, a small hip circumference (<115 cm) was a 
better predictor of the metabolic syndrome compared to a large waist circumference (>100 
cm).  Results from a large Danish cohort reported mortality rate ratios per 10% increase in 
hip circumference and per 10% smaller waist circumference.  Mortality rate ratios were 
similar across anthropometric measures.7  Estimates associated with a 10% change in HC or 
WC were 0.52 and 0.63, respectively, in men; and 0.60 and 0.76, respectively, in women. 
The evidence related to blood pressure is limited and less supportive of a protective 
association.  Although blood pressure may be inversely associated with hip circumference, 
the association tends to be very weak or not statistical significance.  In the Quebec Family 
Study, there was a slight inverse relationship of hip circumference with systolic and diastolic 
blood pressure in women.9  The beta coefficient (SE) for the association of quintiles of hip 
circumference with systolic and diastolic blood pressure, when adjusted for waist 
circumference, age and BMI, were -0.22(0.125) and -0.086(0.079), respectively.  In men the 
association was small but positive.  Beta coefficients (standard error (SE)) were 0.31 (0.23) 
for SBP and 0.127 (0.144) for DBP in men.  
Most studies have been conducted in Caucasian populations.  However, one study 
examined the association of hip circumference with blood pressure, serum glucose and lipid 
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levels in non-Caucasian populations.90   This study population included Melanesians, 
Micronesians, Indians and Creole from Maurtitius, Rodrigues, Papua New Guinea and 
Nauru.  This study evaluated the association of hip circumference with the outcome by 
comparing the magnitude and direction of the standardized beta coefficient for WC and HC 
when adjusted for each other and for age and BMI.  In all ethnic groups, a larger hip 
circumference was associated with lower glucose and triglyceride levels in both sexes and 
higher high-density lipoprotein levels in women only, after adjustment for waist 
circumference, BMI, and age. Standardized beta coefficients associated with serum lipid and 
glucose levels ranged from -0.1 to -0.3 for hip circumference and 0.1 to 0.4 for waist 
circumference among men and women.  There was an inverse trend associated with blood 
pressure for most ethnic groups but it was not significant.  
In most studies, collinearity of anthropometric measures was evaluated.  These 
studies have not reported a need to limit the analytic approach due to collinearity.   
C. Preliminary Studies 
To our knowledge, our research group published the only study, directly comparing 
the incidence of hypertension by BMI among Chinese Asians, American Whites and 
American Blacks.92  Our results support a stronger influence of BMI on incident 
hypertension among Chinese Asians compared to American Whites.  However, at baseline, 
subjects were 45-64 years old.  At this stage of life there exists a high, differential prevalence 
of hypertension between ethnic groups.  The adjusted prevalence of hypertension among 
Chinese Asians, American Whites and American Blacks was 29.6, 22.5 and 44.2%, 
respectively.  This preliminary work made us question how the prevalence of cases at 
baseline, which are excluded from the incidence analysis, influenced the relationship of BMI 
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with incident hypertension.  We began to question whether a greater sensitivity to BMI may 
exist among certain ethnicities at younger ages.  To further explore the effect of BMI on 
incident hypertension, we propose to examine the relationship in a younger adult population 
of Chinese Asians, American Whites and American Blacks, aged 24-30 years. 
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Table 2.1. Hypertension prevalence by age, NHANES 2003-2004  
Age (years) Hypertension Prevalence (%) 
18 – 39 7.3 
40 – 59 32.6 
60+ 66.6 
Source: Ong KL, Cheung BM, Man YB, et al. Prevalence, 
awareness, treatment, and control of hypertension among United 
States adults 1999-2004. Hypertension 2007;49:69-75. 
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Table 2.2.  Age-adjusted hypertension prevalence by race in the MESA cohort 
Race Hypertension prevalence 
Chinese American 39% 
White American 38% 
Black American 60% 
Source: Kramer H, Han C, Post W, et al. Racial/ethnic differences in hypertension 
and hypertension treatment and control in the multi-ethnic study of atherosclerosis 
(MESA). Am J Hypertens 2004;17:963-70. 
 
 
  
  
 
III. METHODS  
A. The People’s Republic of China (PRC) Study data 
The PRC Study is a prospective, observational study of cardiovascular disease in 
China.  This was a joint research program sponsored by the National Institutes of Health 
(NIH) involving the People’s Republic of China and the United States of America under the 
USA-PRC Cooperation in Science and Technology to conduct prospective studies on CVD 
and its risk factors.  In 1983–1984, baseline data were collected from 13,210 Chinese men 
and women aged 24 – 84 years.  Participants were from urban and rural regions of Beijing 
(Northern China) and Guangzhou (Southern China).  Follow-up examinations were in 1987-
88 and 1993-94.  Within Guangzhou, there were 1,848 subjects between the ages of 24-35 
(n=1,077 female and n=771 male) and 6,575 subjects were between the ages of 45 to 64 at 
baseline (n= 3,286 female and n=3,289 male).  Sample sizes for follow-up visits for the full 
study population, aged 24-84 years, are listed in Table 3.1.  
Cluster sampling of age eligible men and women was collected from 4 populations in 
China (Beijing urban, Beijing rural, Guangzhou urban and Guangzhou rural).  Additional 
subjects, comprising a younger age range, were sampled in the urban and rural regions of 
Guangzhou.  Supplementary questions and measurements were collected among subjects 
from Guangzhou, including parental history of hypertension and hip circumference measures. 
Therefore, because we are interested in these variables as well as the younger subset of 
Chinese aged 24-35, our analyses were limited to adults from Guangzhou.  Urban 
participants were currently working or retired employees from eight workshops of the 
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Guangzhou Shipyard Company and rural participants worked in 14 of the 21 agricultural 
villages in the Dashi Township of Panyu County at the time of the 1981 census. 
1. Variables   
a. Height  
Height without shoes was measured to the nearest centimeter by using a standard 
right angle device. 
b. Weight  
Weight was measured to the nearest kilogram by using a spring balance. The 
participant was in typical indoor clothing without shoes. 
c. Hip and waist circumferences 
Circumferences of the waist and hip were measured to the nearest 0.1 cm. Waist was 
measured by passing the tape measure through the midpoint between the superior iliac crest 
and the lowest rib. Hips were measured at their maximum protrusion. 
d. Blood pressure  
 Trained certified technicians measured blood pressure three times at each visit using a 
random zero mercury sphygmomanometer on the right arm with the participant seated.  The 
average of the last two measurements were used in the analyses. 
e. Blood pressure medication use 
Blood pressure medication use was self-reported on participant questionnaires at each 
visit.  
f. Parental history of hypertension  
Parental history of hypertension was assessed by self-report at baseline among the 
Guangzhou sample.  Individuals reported whether their mother, father, both or neither 
 27 
parents had high blood pressure.  Subjects had the options to report unknown but this was not 
selected for any participants.  Responses were not validated.  Subjects were classified as 
having a parental history of hypertension if hypertension was reported by at least one parent. 
g. Lipids 
Subjects were advised to fast for 12 hours prior to clinic visit.  Fasting blood 
specimens were obtained at each visit.  Guangzhou had lipid laboratories for standardized 
analyses of total cholesterol (TC), high-density lipoprotein (HDL) cholesterol and 
triglycerides (TG) by the Lipid Standardization Program of the U.S. National Heart, Lung 
and Blood Institute (NHLBI) and the Centers for Disease Control and Prevention (CDC).  
Serum TC was measured with the Boehringer Mannheim Diagnostics high-performance 
enzymic reagent calibrated with precise standards on the Abbott analyzer.  Serum TG was 
determined with use of an enzymic reagent from Abbott Laboratories.  Serum HDL was 
measured using the same enzymatic serum cholesterol method after precipitation of other 
lipid fractions with dextran sulfate. 
h. Glucose 
Subjects were advised to fast for 12 hours prior to clinic visit.  Fasting blood samples 
were drawn to assess glucose levels. All biochemical assays were performed on an Abbott 
autoanalyzer. 
i. Demographic characteristics 
Age, education, smoking and alcohol consumption were self reported on 
questionnaires.  
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2. Quatlity Control 
Quality control of blood samples was undertaken by the CDC by analyzing a random 
sample. 
B. The Coronary Artery Risk Development in Young Adults (CARDIA) Study data 
The CARDIA Study, funded by the NHLBI, is an on-going, prospective, multi-site 
investigation examining the etiology of heart disease in young adults.  In 1986-87, baseline 
data were collected from 5,115 Black and White American men and women aged 18-30 
years. Participants were from four U.S. sites (Birmingham, AL; Chicago, IL; Minneapolis, 
MN; and Oakland, CA) to provide approximately equal numbers within subgroups of race, 
gender, education (high school or less and more than high school) and age (18-24 and 25-30).  
Follow-up examinations occurred during 1987-1988 (Year 2), 1990-1991 (Year 5), 1992-
1993 (Year 7), 1995-1996 (Year 10), 2000-2001 (Year 15), and 2005-2006 (Year 20).  The 
retention rate at each follow-up visit is 90% (Year 2), 86% (Year 5), 81% (Year 7), 79% 
(Year 10), 74% (Year 15), and 72% (Year 20), respectively. 
1. Variables 
a. Height  
Participants were standing, without shoes, when height was measured to the nearest 
0.5 centimeter using a vertical ruler. 
b. Weight 
Weight was measured to the nearest 0.5 pound using a beam balance scale.  
Participants were dressed in a scrub suit or short sleeve shirt and shorts without shoes. 
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c. Blood pressure 
Resting blood pressure was measured three times at each visit using a random zero 
mercury sphygmomanometer (RZ) on the right arm of a seated participant. Participants were 
advised to restrain from caffeine, alcohol, smoking (30 min) or heavy physical exercise for at 
least 2 hours prior to visit.  The average of the last two measurements were used in the 
analyses 
d. Blood pressure medication use 
Medication records were collected at each clinic visit by self-reported questionnaires 
followed by interviewer assisted follow-up as needed. 
e. Demographic characteristics 
Age, sex, race, highest education obtained, smoking status, drinking status and 
geographic field center were collected via interviewer administered questionnaires. 
2. Quality Control  
The CARDIA Coordinating Center, and the CARDIA Quality Control Committee 
monitored data collection throughout the study and all data collection technicians were 
centrally trained and certified. Informed consent was obtained from each participant at each 
examination. 
C. The Atherosclerosis Risk In Communities (ARIC) Study data 
The ARIC study is a prospective, multi-site investigation of atherosclerosis and 
cardiovascular disease 93.  Baseline data were collected from 1987-1989 in 15,792 African 
American and White men and women, 45-64 years of age.  Races other than African 
American or White (n=48) and African Americans in Minneapolis and Washington County 
(n= 55) were excluded per standard ARIC protocol because their numbers are too small to 
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allow ethnic and field-center specific analyses, leaving 15,689 participants.  These 
participants were from four communities in the United States:  Forsyth County, NC (12% 
African American; 88% White); Jackson, MS (100% African American); the northwestern 
suburbs of Minneapolis, MN (100% White); and Washington County, MD (100% White).  A 
range of physiologic and behavioral risk factors were measured.  Participants were measured 
in a maximum of four clinic visits at approximately three year intervals.  We excluded visit 3 
from our analysis.  
1. Variables 
a. Height   
Height was measured to the nearest centimeter using a metal rule attached to a wall 
and a standard triangular head board.  
b. Weight 
Weight was measured to the nearest pound using a beam balance with subjects in a 
scrub suit and no shoes.  
c. Physiologic risk factors  
Systolic and diastolic blood pressures were measured three times after a 5-minute rest 
using a random zero sphygmomanometer on the right arm of the seated participant.  The last 
two measures were averaged and recorded.    
d. Blood pressure medication use 
Medication records were collected at each clinic visit. Participants were reminded to 
bring all medications used in the previous two weeks.  Names of the medications were 
transcribed and coded by the ARIC medication coding system, developed by a pharmacist at 
UNC.  Subjects were classified as taking blood pressure medication if they self-reported 
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taking medications in general in the last two weeks, and the medications they brought 
included an appropriately classified medication.   
e. Covariates 
Age (date of birth), race/ethnicity, and gender were self-reported.  Additional 
covariates were assessed by interviewer-administered questionnaires.  We categorized 
education as less than a high school education, high school graduate, or at least some college.  
Self-reported cigarette smoking status and alcoholic beverage consumption were categorized 
into current use yes or no variable.  The field center variable was used.  
2. Quality control 
ARIC field centers used a computer-assisted data collection system in which staff 
directly recorded the information collected from interviews and examinations.  Rigorous 
quality control procedures were developed and implemented for all parts of the examination 
to ensure that data were collected uniformly at each center and over time.  The Collaborative 
Studies Coordinating Center at the University of North Carolina at Chapel Hill served as the 
study coordinating center.  Several papers evaluating quality control in the ARIC study have 
been published 94-101. 
D. Analytic methods 
Methods used in individual papers are summarized in those chapters.  Additional 
methodological details are listed below.   
1. Risk Differences 
Comparisons of the effect of obesity between ethnic populations are susceptible to 
spurious conclusions depending on the use of multiplicative or additive risk estimates.  As 
demonstrated by Stevens et al., conclusions regarding the relative effect of obesity in Black 
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vs. White adults were contradictory when employing risk ratio vs. risk difference 
measures.102  This was attributed to differences in the rate at the reference level of adiposity 
between ethnic groups and the impact of these differences when using a multiplicative as 
opposed to an additive risk assessment.  This is one of the main reasons epidemiologists 
encourage the use of risk difference measures to estimate risk.   Therefore, for each aim, we 
calculated the risk difference to estimate risk.  
2. “PRvalue” command 
The prvalue command by Long and Freese is a user-friendly Stata method to compute 
post-estimation predictions of outcomes at specific values of the independent variables.103, 104  
After specifying the logistic regression model, values of the independent variables are 
specified using the “prvalue save” command which then computes the predicted value of the 
outcome.  Difference measures or changes in the predictions at values of the independent 
variables were computed using the “prvalue diff” command and specifying levels of the 
independent variables.  Confidence intervals for both predicted outcomes and discrete 
changes in predictions were computed using the delta method. 
3. The delta method 
The delta method was used to calculate confidence intervals for the predicted 
estimates in Stata with the “prvalue” command.  The delta method generates confidence 
intervals for functions of maximum likelihood estimates by creating a linear approximation 
of that function and then computing the variance of the simpler linear function that can be 
used for large sample inference.103, 104  It is a technique used when functions are too complex 
to analytically compute the variance.  This is the case for our analyses where confidence 
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intervals were estimated around the change (risk difference) in the predicted probabilities 
based on a logistic model. 
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Table 3.1. Sample size for 24-84 year olds in PRC 
  PRC   
             Total   
        N          % 
 
 N 
Guangzhou 
% 
Baseline 13,210 100 7,066 100 
Visit 2  11,440 86.6 6,167 87.3 
Visit 3  9,483 71.8 5,730 81.1 
Completed all  3 Visits 8,674 65.7 5,270 74.6 
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Table 3.2.  Examination years by cohort 
 Cohort Exam Year 
Visit # PRC CARDIA ARIC 
1 1983-84 1985-86   1987-89 
2 1987-88 1987-88 1990-92 
3 1993-94 1990-91 1993-95 
4  1992-93 1996-98 
5  1995-96    
6  2000-01    
7  2005-06  
Bolded exam years indicate those used in our analyses 
 
  
IV. IMPACT OF BODY MASS INDEX ON INCIDENT HYPERTENSION IN AMERICAN WHITE, 
AMERICAN BLACK AND CHINESE ASIAN ADULTS IN EARLY AND MIDDLE ADULTHOOD 
A. Abstract 
Background: The impact of body mass index (BMI) on blood pressure is thought to 
be stronger in Asian than non-Asian populations.  However, longitudinal studies with direct 
comparisons between ethnicities are lacking.   
Objective: To compare the ethnic-specific relationship of BMI with incident 
hypertension in young (24-39 years) and middle-aged (45-64 years) adults.  
Methods: Chinese Asians (young (n=2,896) and middle-aged (n=2,458)) adults were 
from the People’s Republic of China study, American Black (n=1,956 young and n=4,120 
middle-aged) and American White (n=2,114 young and n=11,337 middle-aged) adults were 
from the Coronary Artery Risk Development in Young Adults (CARDIA) study and the 
Atherosclerosis Risk in Communities (ARIC) study.  The incidence of hypertension and the 
incidence difference were calculated using a referent BMI of 21 kg/m2.   
Results: The incidence difference for hypertension associated with BMI was larger 
(p<0.05) for Chinese Asians than American Whites and American Blacks in both age groups.  
At a BMI of 25 kg/m2 the incidence difference per 1,000 persons (95% CI) for Chinese, 
Blacks and Whites was 83 (36, 130), 50 (26, 74) and 30 (12, 48) among young adults and 
137 (77, 198), 49 (9, 88) and 54 (38, 69) among middle-aged adults, respectively. 
Conclusion: The association of BMI with the incidence difference for hypertension 
was greater in Chinese than in American populations during both young and middle-
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adulthood.  However, whether hypertension carries the same level of risk of stroke or 
cardiovascular disease across different national or ethnic groups remains uncertain.
B. Background 
Studies in China have shown that the risk of hypertension and other cardiovascular 
related risk factors increase with increasing BMI within the normal BMI range considered 
normal2-4, 13, 28, 105-109 according to World Health Organization standards (<25 kg/m2).  These 
studies 2-4, 13, 28, 105-109, which typically lack a Caucasian comparison group, have concluded 
that a BMI of 23-24 kg/m2 may be a better cutpoint to define overweight in Chinese 
populations.    The China Department of Disease Control Ministry of Health responded to the 
body of literature by adopting country specific BMI cutpoints which define overweight and 
obesity at BMI values of  >24 kg/m2 and >28 kg/m2, respectively, lower thresholds than 
those established by the World Health Organization of >25 kg/m2 and >30 kg/m2, 
respectively.110      
To our knowledge, our research group published the only study 92, directly comparing 
the incidence of hypertension by BMI among Chinese Asians, American Blacks and 
American Whites.  Our results supported a stronger influence of BMI on incident 
hypertension over approximately 8 years of follow up among adults who were 45-64 years of 
age at baseline.  Although the BMI associated incidence rate was higher in Chinese Asians, 
the BMI-adjusted prevalence of hypertension was similar among Chinese Asians (29.6%) 
and American Whites (22.5%), and substantially higher in American Blacks (44.2%).   
Since the prevalence was higher in 45-64 year old American Blacks, we wondered if 
the sensitivity of hypertension to BMI would be stronger in American Blacks at younger ages 
(<45 years) while Chinese Asians were more sensitive at older ages (>45 years).  
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Alternatively, the high prevalence of hypertension in American Blacks could be unrelated to 
BMI and due to other factors.  We hypothesized that the American Blacks who were 
susceptible to developing hypertension in response to adiposity had already developed the 
disease by the age of 45, whereas, in Chinese Asians more years had to be accrued before 
they became sensitive to the effects of BMI on disease.  The idea that susceptibility to the 
effects of BMI might differ by age in different ethnic groups led us to examine these 
associations in a younger cohort of Chinese Asians, American Blacks and American Whites 
and compare results to a middle-aged population.  We speculated that the effects of BMI on 
hypertension incidence would be highest in American Black young adults, lowest in Chinese 
Asians young adults, and intermediate in American White young adults; whereas, BMI 
effects in middle aged adults would be highest in Chinese Asians, lowest in American Blacks 
and again intermediate in American Whites. 
C. Methods 
1. Study population 
Data for this analysis were from Chinese Asian, American Black and American 
White men and women from three prospective, observational studies of the natural history 
and risk factors for cardiovascular disease (Table 4.1).  In an effort to be concise, we will 
refer to the three ethnic groups as Chinese, White and Black throughout the remainder of the 
paper.  Chinese (young and middle-aged adults) were from the People’s Republic of China 
(PRC) study, Black and White adults were from the Coronary Artery Risk Development in 
Young Adults (CARDIA) study (young) and the Atherosclerosis Risk in Communities 
(ARIC) study (middle-aged).  We limited the use of data from each cohort to three 
examinations to result in similar lengths of follow up for Chinese, Blacks and Whites, 
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respectively, in young (9.5, 9.3, 9.7 years) and middle (9.0, 7.2, 7.9 years) adulthood.  We 
also matched the ages of participants in these different cohorts by including only participants 
between 24-39 or 45-64 years of age.   
 
The PRC Study data  
The PRC Study included adult working men and women from urban and rural regions 
of Guangzhou (Southern China) and Beijing (northern China), with a "chunk" sample of at 
least 2,000 adults (1,000 men and 1,000 women) from each population.  Subjects were 
limited to those from Guangzhou as data from Beijing were very limited for the young adult 
group.   Request to participate was made to age-eligible males and females.  The Guangzhou 
urban sample included largely employed manual workers, plus some engineers, technicians, 
cadres, physicians, and retired workers from eight of the 25 workshops for the Guangzhou 
Shipyard Company.  The Guangzhou rural sample included men and women working in 14 
of 21 agricultural villages near Guangzhou in the Dashi township of Panyu County at the 
time of the 1981 census.111  Baseline data were collected in 1983–1984, from 6,581 Chinese 
men and women.  Follow-up examinations were in 1987-88 and 1993-94.   
 
The CARDIA study data  
The CARDIA Study is an on-going, multi-site investigation examining young adult 
Black and White men and women.112, 113  In 1985-86, study baseline data were collected from 
participants recruited from four U.S. sites (Birmingham, AL; Chicago, IL; Minneapolis, MN; 
and Oakland, CA) with the goal to provide approximately equal numbers within subgroups of 
race, gender and education.  To match follow-up period and age ranges of subjects in PRC, 
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we used data from 1990-1991 (CARDIA study Year 5) as baseline for this analysis and data 
from 1995-1996 (Year 10) and 2000-2001 (Year 15) for follow-up examinations.   
 
The ARIC study data  
The ARIC study is an on-going investigation 114 with baseline data collected in 1987-
1989 from 15,792 White and Black men and women, aged 45-64 years.  Participants were 
from four U.S. communities (Forsyth County, NC; Jackson, MS; the northwestern suburbs of 
Minneapolis, MN; and Washington County, MD).  The two follow up examinations used in 
this analysis occurred during 1990-92 and 1996-98.  
There are many similarities in the design and data collection among the three cohorts. 
The Collaborative Studies Coordinating Center (CSCC) at the University of North Carolina 
at Chapel Hill served as the coordinating center for both the PRC and ARIC studies.  The 
coordinating center provided training manuals and protocols for data collection and was 
responsible for data processing and review for both studies.  The Institutional Review Board 
(IRB) at each field center approved the study and this analysis was approved by the 
University of North Carolina at Chapel Hill IRB on research involving human subjects.  
2. Measurements 
For all three studies data were collected in examination centers.  In each cohort, 
participants wore light clothing or a scrub suit without shoes during anthropometric 
measurements.    
Trained certified technicians measured and recorded blood pressure three times at 
each visit using a random zero mercury sphygmomanometer on the right arm with the 
participant seated.  For all analyses, the average of the last two blood pressure measurements 
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was used.  Information on anti-hypertensive medication use was collected by self-reported 
questionnaires and followed by interviewer assisted follow-up as needed.  Blood pressure 
thresholds were based on the National High Blood Pressure Education Program Seventh 
Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment 
of High Blood Pressure.115  Participants were classified as hypertensive if 1) systolic blood 
pressure was greater than or equal to 140 mmHg, 2) diastolic blood pressure was greater than 
or equal to 90 mmHg or 3) self-report of current antihypertensive medication use.   
Participants self-reported several demographic and lifestyle information including 
age, sex, race, current smoking status and highest education obtained.  We did not have 
measures of diet for PRC and measures of physical activity were not comparable across 
studies and therefore were not included.   
In young adults, participants were excluded if pregnant at baseline (n=23 Black and 
n=33 White), missing BMI (n=11 Chinese, n=13 Black and n=8 White), missing blood 
pressure (n=2 Black and n=1 White) or missing covariates (n=17 Chinese, n=8 Black and 
n=9 White).  The analysis sample included 2,896 Chinese, 1,956 Black and 2,114 White 
young adults.  For the incidence analysis we also excluded participants with hypertension at 
baseline (n=81 Chinese, n=128 Black and n=61 White), pregnant during follow-up (n=3 
Chinese, n=7 Black and n=30 White) and subjects with incomplete follow-up data (n=426 
Chinese, n=428 Black and n=311 White).   
In middle-aged adults, we excluded 55  Blacks from Washington County, MD or 
Minneapolis, Minnesota, and the participants (n=48) who classified their ethnicity as other 
than White or Black because they were too small in number to allow ethnic and field center 
specific analyses.  Additionally, participants were excluded if missing BMI (n=11 Chinese, 
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n=19 Black and n=20 White), missing blood pressure (n=2 Black and n=3 White), missing 
covariates (n=16 Chinese, n=15 Black and n=15 White).  The analysis sample included 2,458 
Chinese Asian, 4,120 Black and 11,337 White in the middle-aged adult prevalence sample.  
For the incidence analysis we also excluded participants with hypertension at baseline 
(n=355 Chinese, n=2,400 Black and n=3,721 White) and incomplete follow up data (n=508 
Chinese, n=470 Black and n=1,268 White). 
3. Statistical analyses 
Interactions between gender and BMI were not significant and therefore data from 
men and women were combined and analyses were stratified by ethnic-specific age group 
and gender was included as a covariate in all models.  Logistic regression models also 
included the covariates field center, age (years), current smoking status (smoker/non-
smoker), and education level (less than high school, high school, more than high school in 
American populations and the best equivalent of less than secondary, secondary and greater 
than secondary in the Chinese population).  As a large proportion of Chinese were missing 
education status, we created a category for unknown education for PRC.  For all outcomes, 
the alcohol consumption was included as a covariate in preliminary models but was not 
included in the final models because associations of alcohol with outcomes were not 
statistically significant (p>0.05) and inclusion of alcohol in the models did not influence the 
coefficients associated with variables of interest. 
We estimated risk differences using logistic regression models and calculated the 
adjusted prevalence and incidence and the incidence difference using the “prvalue” command 
103, 104
 in Stata (Version 10.0).  To facilitate comparisons across ethnicities, standardized 
estimates were calculated using the mean age (32 years for young adults and 52 years for 
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middle-aged adults), the overall distribution of gender (44% male), for non-smokers with a 
high-school or secondary education and the study specific distribution of participants within 
field centers.  Quadratic terms for BMI and age were tested and included as they were 
statistically significant (p<0.05).  The delta method was used to calculate the standard errors 
and 95% confidence intervals for the prevalence, incidence and incidence difference.  To 
summarize the ethnic-specific incidence difference results across body mass index, we 
constructed weighted least-squares regression models with the adjusted incidence differences 
as the dependent variables and the body mass index as the independent variables.  The 
adjusted incidence differences were calculated for the body mass index range of 18-35 kg/m2.  
The weight was the inverse of the estimated variance of the adjusted incidence difference.  
Wald statistics and p values were calculated based on chi-square distribution with 1 degree of 
freedom (d.f.) to compare ethnic group pairs when the relationships were linear.  When the 
relationships were quadratic, principal component analysis was used to orthogonally 
transform the linear and quadratic terms for BMI.  Joint tests of the linear and quadratic 
terms to compare ethnic pairs were calculated using the Wald statistic and the p values were 
calculated based on chi-square distribution with 2 d.f.  
D. Results 
Baseline characteristics are presented in Table 4.2.  Mean BMI was lowest among 
Chinese (20 kg/m2) and over 90% of the Chinese were underweight (BMI <18.5 kg/m2) or 
normal weight (BMI 18.5-<25 kg/m2).  Antihypertensive medication use was negligible 
among young-adult Chinese (0.1%) and Whites (0.7%) and slightly more common among 
Blacks (2.6%).   Use of antihypertensive medication was low among middle-aged Chinese 
(1.5%), and higher among the American populations (43.7% in Blacks and 25.9% in Whites).  
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We also examined the mean values of systolic and diastolic blood pressure among 
individuals who were not using antihypertensive medications.  Mean systolic and diastolic 
blood pressure were lower in the non-medicated sample by 0.5-2.7 mmHg and 0.3-1.3 
mmHg, respectively, compared to the overall population (not shown).   
The crude and adjusted, predicted prevalence and incidence of hypertension are 
presented in Table 4.3.  As expected, prevalence estimates were lower for young adults than 
middle-aged adults.  The adjusted incidences and prevalence tended to be highest in Blacks.   
The prevalence of hypertension was similar in Chinese and Whites.  The incidence was also 
similar, but higher in the Chinese and older adults.  Among young adults, the adjusted 
prevalence of hypertension was significantly greater for Blacks (4.4 (2.4, 6.4)) compared to 
Whites (1.1 (0.3, 2.0)).    Ethnic specific patterns for the incidence were similar to those 
observed for prevalence.  In young adults, the adjusted incidence of hypertension was higher 
in Blacks (18.5 (13.9, 23.1)) compared to Chinese (5.3 (2.9, 7.6)) and Whites (6.1 (3.5, 8.6)).  
Among middle-aged adults, the adjusted prevalence of hypertension was considerably higher 
in Blacks (40.0 (35.1, 45.0)) compared to Chinese (17.2 (9.2, 25.3)) and Whites (17.5 (15.9, 
19.2)) (Table 4.3).  The adjusted incidence of hypertension was higher in Blacks (35.4 (27.2, 
43.7) than Whites (20.8 (18.5, 23.2) and Chinese (30.5 (18.4, 42.6), but the difference was 
not significant between Blacks and Chinese.   
 The incidence differences for hypertension increased with increasing BMI for all 
ethnic groups in both young and middle adulthood.  Among young adults, although there 
were differences in the adjusted incidence at the referent BMI of 21 kg/m2 (Table 4.3), the 
incidence difference for hypertension associated with BMI was similar for Blacks and 
Whites.  However, in Chinese the association of BMI with the incidence difference for 
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hypertension was significantly greater compared to the American populations (p=0) (Figure 
4.1).  Among middle-aged adults, the association of BMI with the incidence difference for 
hypertension was also greater among Chinese compared to Blacks and Whites (p<0.01) 
(Figure 4.2).   
E. Discussion 
We did not find support for our hypothesis that BMI associations with hypertension 
incidences would be greatest in Black young adults.  Instead, associations between BMI and 
the incidence difference for hypertension were greatest in Chinese in both young and middle 
adulthood.  In contrast, the adjusted prevalence and incidence of hypertension tended to be 
higher in Blacks than in Chinese and similar among Chinese and Whites in adjusted 
predicted estimates for slender individuals (BMI 21 kg/m2).  Despite these differences in the 
adjusted prevalence and incidence of hypertension between ethnic groups, the Chinese had a 
stronger association of BMI with the incidence difference for hypertension compared to 
Blacks and Whites as evidenced by the steeper slope of the incidence difference.  Although 
the adjusted incidence for hypertension at the referent BMI was different between Blacks and 
Whites, the slope of the incidence difference was similar between these American 
populations but different from the Chinese.  While both young and middle-aged Blacks have 
a high prevalence and incidence of hypertension across all BMI values, the association of 
BMI with the incidence difference for hypertension was not as strong as that observed for 
Chinese.  This combination of results indicates that hypertension incidence is more strongly 
related to BMI in Chinese than Blacks or Whites and the higher prevalence and incidence of 
hypertension in Blacks compared to Chinese is likely due to factors other than BMI.  Blacks 
may experience hypertension due to additional risk factors beyond obesity, which were 
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unmeasured in our study, such as dietary factors, physical activity, environmental stressors or 
potentially genetic differences.116-118   
Studies in China and the United States have shown increasing prevalence and 
incidence of hypertension associated with an increase in BMI.  However, few studies have 
compared the association in both Chinese and Caucasian populations 67-71, 92, 119 and even 
fewer have studied the relationship in Chinese, Caucasian and African American 
populations.67, 68, 92  In addition, comparisons of the effect of obesity between ethnic 
populations typically employ ratio measures which must be interpreted carefully.  As 
demonstrated by Stevens et al.120 conclusions regarding the relative effect of obesity in Black 
versus White adults were contradictory when calculated as risk ratio versus risk difference 
measures.  This was driven by differences in the rate at the reference level of adiposity 
between ethnic groups and the impact of using a multiplicative as opposed to an additive risk 
assessment.102, 121  Therefore, we calculated difference measures to compare estimates among 
ethnic groups. 
In addition to the use of ratio measures, the majority of analyses which assess ethnic 
differences in the BMI-hypertension relationship were cross-sectional in design.  This limited 
the ability to understand temporal sequences of associations.  Bell et al. 122 used cross-
sectional data to compare the adjusted prevalence and odds of hypertension in 30–65 year old 
Chinese Asian adults from the China Health and Nutrition Survey with American Black and 
White adults from the Third National Health and Nutrition Examination Survey (NHANES 
III).  At the referent range of BMI (18.5-22.9 kg/m2), the odds of hypertension was low in 
Chinese and high in American Blacks.  The authors found the age-adjusted odds ratio for 
hypertension was significantly greater in Chinese Asian men, at BMI values in the upper 
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normal, overweight and obese categories, when compared to American White men from 
NHANES III.  Similarly, Chinese Asian Women had a significantly higher odds ratio for 
hypertension when compared to American White women within the BMI range of 27-28.9 
kg/m2.   
Pan et al. 68 compared American Whites and Blacks from NHANES III to a 
Taiwanese Asian population from the Nutrition and Health Survey in Taiwan.  Similar to 
Bell’s results, the adjusted prevalence of hypertension was higher (p<0.017) in American 
Blacks compared to Taiwanese Asians and the age and sex standardized prevalence of 
hypertension was steeper across BMI levels in the Taiwanese compared to American Blacks 
and Whites.  The odds ratio (95% CI) per unit change in BMI was highest in Taiwanese (1.24 
(1.11, 1.39)) compared to both American Whites (1.11 (1.09, 1.14)) and Blacks (1.07 (1.05, 
1.09)) and significantly different between Taiwanese and American Blacks.  BMI cutoffs that 
maximized the sum of the sensitivity and specificity in predicting hypertension were between 
23.3 kg/m2 and 23.7 kg/m2 for Taiwanese males and females, respectively, and between 25.6-
28.2 kg/m2 for American White and Black males and females. 
The Obesity in Asia collaborative (OAC) addressed the relationship of 
anthropometric measures with cardiovascular risk factors in Asian compared to Caucasian 
populations by combining existing data sources.70  Asians within China, Hong Kong, India, 
Korea, Japan, Singapore, Thailand, and Taiwan were collectively compared to Caucasians 
within Australia and Iran.  The effect of excess adiposity on blood pressure was assessed by 
examining the increase in systolic blood pressure, diastolic blood pressure or the odds of 
hypertension associated with a cohort specific 0.5 standard deviation change in BMI.  Results 
from the meta-analyses did support a greater risk of hypertension and other CVD related risk 
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factors in Asians compared to Caucasian populations.  However, genetic and environmental 
heterogeneity in body composition between Asian populations have been reported and thus 
information may be lost when collectively assessing various Asian ethnicities.14  In addition, 
a 0.5 standard deviation change may encompass different values and ranges across 
populations. 
Razak et al. 69, 71 analyzed cross-sectional data from Canadian Chinese and 
Caucasians from the Study of Health Assessment and Risk in Ethnic groups (SHARE) 
cohort.  All subjects resided in Canada for a minimum of five years prior to data collection.  
The 2005 study found an increase in median systolic blood pressure with increasing BMI 
quintile in both Caucasian and Chinese populations with adjustment for age and sex.71  The 
increase was steeper in the Chinese compared to Caucasians.   
From this and other studies, the association of obesity with hypertension in Chinese 
populations appears stronger than that observed in non-Asian populations, even within 
normal BMI ranges (18.5 kg/m2<BMI<25 kg/m2).  Although the proportion of adults, who 
are overweight or obese in China, is less than that of the United States, the rate of increase in 
obesity in China is much more rapid.  In the time since data was collected for this study, the 
prevalence of obesity has increased dramatically within Mainland China.123  Our population 
of Chinese adults was very lean in 1983-84, as less than 6% had a BMI of 25 kg/m2 or 
higher.  More recent estimates suggest 21%, or more than 1.1 billion of the mainland adult 
Chinese population are overweight or obese (BMI >25 kg/m2).124  Despite the leanness of our 
sample, the association of BMI with blood pressure was significantly greater than that of 
American populations where the mean BMI is much higher.125  123  40. 1  
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The stronger association of BMI with hypertension among Chinese compared to 
American populations which were observed in this and other studies may be due to regional 
differences.  Chinese Asians may have become overweight more recently, while the 
American populations were overweight since childhood or adolescence.   Differences in the 
duration of excess weight may influence the association of BMI with hypertension.  In 
addition, factors related to weight and blood pressure which affected Chinese Asians as 
children and adults may be quite different from those of the American samples.  One of the 
limitations of our study was that we could not separate these regional differences from ethnic 
differences.    
Another limitation was the lack of diet and physical activity data.  Data from the 
CARDIA study have shown blood pressure was inversely associated with physical activity, 
dietary potassium and protein and these factors accounted for some of the ethnic differences 
in blood pressure levels.126 In China, diet and physical activity have also been linked to 
regional differences in blood pressure.39   Without comparable measures of diet and physical 
activity between populations, we cannot determine whether the stronger association of BMI 
with hypertension incidence in Chinese compared to U.S. populations was due to differences 
in diet and physical activity.  
This is the first longitudinal study to examine the association of BMI with 
hypertension and elevated blood pressure in Chinese Asians, American Blacks and American 
Whites during two different stages of adulthood.  Strengths of this work include the use of 
the CARDIA, ARIC and PRC datasets which provide some of the best data currently 
available, given our goals.  There are many similarities between cohorts, including the study 
design and data collection, quality control, longitudinal design and use of measured 
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anthropometry.  Further strengths of our study include the use of continuous BMI rather than 
categorical and computing estimates using difference measures rather than ratio measures to 
compare risks across ethnicities.  This study is limited in that ethnic groups are from different 
countries (however, data do not exist for a large U.S. cohort of Chinese Americans), the 
overlay of ethnicity and social factors, geography and nationality cannot be separated, we did 
not have measures of diet for PRC and measures of diet and physical activity were not 
comparable across ethnic groups and lastly although each sample is representative of their 
geographical region, they are not nationally representative.  There are also differences in 
calendar year across samples but because the PRC sample is from China and the CARDIA 
sample is from the U.S., we did not expect calendar time to be as relevant a criterion to 
match samples as duration of follow up and age range since the environment in China and the 
U.S. are very different for all of the years available.  
Based on the results of our study and relevant literature, the association of BMI with 
blood pressure appears to be stronger in Chinese Asians compared to American White and 
American Black populations.  However, it cannot be ignored that American Blacks have a 
disproportionately high burden of hypertension across all BMI levels.  Further, it is not 
known whether hypertension carries the same level of risk of stroke or cardiovascular disease 
across different national and ethnic groups.  This supports the need for tailored public health 
strategies to promote healthy blood pressure levels and encourage a healthy BMI among 
populations. 
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Table 4.1. Overview of study populations 
  
 Young adults (24-39 years)  Middle-aged adults (45-64 years) 
 
Chinese  
Asian 
(n=2,896) 
American 
Black 
(n=1,956) 
American 
White 
(n=2,114) 
 
Chinese  
Asian 
(n=2,458) 
American 
Black 
(n=4,120) 
American 
White 
(n=11,337) 
Cohort PRC CARDIA CARDIA  PRC ARIC ARIC 
Country of 
origin China U.S.A. U.S.A.  China U.S.A. U.S.A. 
Baseline 
years 1983-84 1990-91 1990-91  1983-84 1987-89 1987-89 
Follow-up 
visits (years 
since 
baseline) 
4 and 10 5 and 10 5 and 10  4 and 10 3 and 9 3 and 9 
Mean (SD) 
follow-up 
time (years) 
9.5 (1.5) 9.3 (1.9) 9.7 (1.5)  9.0 (2.1) 7.2 (2.7) 7.9 (2.3) 
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Table 4.2. Baseline characteristics of young and middle-aged Chinese Asians, American Blacks and American 
Whites 
Young adults (24-39 years) Middle-aged adults (45-64 years) 
Chinese 
Asian 
(n=2,896) 
American 
Black 
(n=1,956) 
American 
White 
(n=2,114) 
Chinese 
Asian 
(n=2,458) 
American 
Black 
(n=4,120) 
American 
White 
(n=11,337) 
BMI (kg/m2, mean 
(SD)) 20.2 (2.1) 27.5 (6.7) 25.0 (4.8) 
 
20.3 (2.8) 29.6 (6.2) 27.0 (4.9) 
BMI categories (%)       
  <18.5 kg/m2 20.1 2.0 2.7 27.1 1.1 0.9 
  >18.5-<25 kg/m2 77.1 39.7 57.2 66.8 20.8 36.2 
  >25-<30 kg/m2 2.6 31.0 27.8 5.7 37.3 40.1 
  >30-<35 kg/m2 0.1 15.0 8.0 0.2 24.5 16.2 
  >35-<40 kg/m2 0.1 6.8 2.6 0.1 10.3 4.7 
  >40 kg/m2 0.0 5.6 1.7 0.0 6.0 1.8 
Age (years, mean (SD)) 33.1 (4.2) 29.8 (3.5) 30.7 (3.2) 51.2 (4.7) 53.5 (5.7) 54.3 (5.7) 
Gender (% Male) 43.5 43.1 48.0 42.8 37.8 47.3 
Education, (%) 
  < high school 75.1 6.7 2.5 87.1 41.8 17.2 
  high school 15.5 62.2 37.2 4.0 28.3 45.4 
  >high school 2.4 31.2 60.3 1.8 30.0 37.4 
Smoke (% current) 33.4 34.8 23.2 38.7 29.8 24.8 
Blood pressure (mmHg, mean (SD)) 
  Systolic  110.5 (11.4) 110.1 (11.9) 106.0 (11.0) 117.0 (18.7) 128.9 (21.5) 118.5 (17.0) 
  Diastolic  69.5 (8.9) 71.1 (10.5) 68.2 (9.5) 74.5 (10.8) 79.8 (12.1) 71.6 (10.1) 
Anti-hypertension 
medication use (%) 0.1 2.6 0.7 
 
1.5 43.7 25.9 
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Table 4.3. Crude and adjusted baseline prevalence and incidence for hypertension by age group and race 
Young  adults (24-39 years)  Middle-aged adults (45-64 years) 
Cases/sample 
size (nos.) 
Adjusted 
estimate 
95% confidence 
interval 
 Cases/sample 
size (nos.) 
Adjusted 
estimate 
95% confidence 
interval 
Hypertension 
Prevalence 
       
  Chinese Asian 81/2,896 2.3 0.8, 3.9  355/2,458 17.2b 9.2, 25.3 
  American 
Black 128/1,956 4.4a 2.4, 6.4 
 
2,400/4,120 40.0a,c 35.1, 45.0 
  American 
White 61/2,114 1.1b 0.3, 2.0 
 
3,721/11,337 17.5b 15.9, 19.2 
 
Hypertension 
Incidence 
 
  Chinese Asian 262/2,386 5.3b 2.9, 7.6  471/1,595 30.5 18.4, 42.6 
  American 
Black 345/1,393 18.5a,c 13.9, 23.1 
 
584/1,250 35.4a 27.2, 43.7 
  American 
White 160/1,712 6.1b 3.5, 8.6 
 
1,955/6,348 20.8b 18.5, 23.2 
a= different than White; b= different than Black; c= different than Chinese based on wald test p<0.05 
Adjusted estimates  represent values for nonsmokers at age 32 for young adults and 52 for middle age adults with a body mass 
index of 21 kg/m2, a high school education in Americans and a primary education in Chinese, 44% distribution of males and the 
distribution of field center.  
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Figure 4.1.  Incidence difference per 1,000 persons for hypertension in young adults (24-39 years), by race 
 
  Joint tests of the linear and quadratic terms to compare ethnic pairs were calculated using the Wald statistic and the p values were 
calculated based on chi-square distribution with 2 d.f. *Estimates for Chinese were significantly different (p<0.05) from Whites and 
from Blacks. 
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Figure 4.2.  Incidence difference per 1,000 persons for hypertension in middle
  Joint tests of the linear and quadratic terms to compare ethnic pairs were calculated using the Wald statistic and the p valu
calculated based on chi-square distribution with 2 d.f. *Estimates for Chinese were significantly different (p<0.05) from W
from Blacks. 
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V. INTERACTIONS BETWEEN OBESITY, PARENTAL HISTORY OF HYPERTENSION AND AGE 
ON PREVALENT HYPERTENSION, THE PEOPLE’S REPUBLIC OF CHINA STUDY   
A. Abstract                                                                                                                                                                                                                 
Objective: To determine if the associations of body mass index (BMI) with 
prehypertension and hypertension vary by parental history of hypertension and by age. 
Methods: Subjects included Chinese adults (n=4,104) from the People’s Republic of 
China Study.  A positive history was indicated if hypertension was reported for either parent.  
Logistic models were stratified by age into 24-39 (young) and 40-71 (middle-aged) year 
groups, and adjusted for age, smoking, alcohol, gender and center.  Prevalence differences 
were determined examining BMI in the continuous linear form using a referent BMI of 18.5 
kg/m2.   
Results:   In both age and parent history groups, BMI was associated with a 
monotonic increase in prehypertension and hypertension.  Among young adults, interactions 
between BMI and parental history were not detected although the prevalence/1,000 persons 
(95% CI) was greater among subjects with a positive parental history (34.8 (15.3, 54.2)) 
compared to a negative parental history (6.9 (3.1, 10.8)) at the referent BMI.  Among middle-
aged adults, at the referent BMI, the prevalence of hypertension was similar in the two 
parental history groups, but the prevalence difference associated with BMI was greater 
among adults with a positive parental history.  For example, at 25 kg/m2, the prevalence 
difference per 1,000 persons was 375 (245, 506) compared to 97 (51, 144).  Trends were 
similar but attenuated for prehypertension.
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 Conclusions: Interactions among BMI, parental history and age were found to 
influence hypertension risk in Chinese.  The substantial size of these effects warrants further 
investigation.  
B. Background 
In China, the prevalence of hypertension among adults aged 18 and older is 
substantial (19%) despite low mean levels of body mass index (BMI) (23 kg/m2).127  Rates of 
hypertension are expected to rise as levels of obesity increase in China.127  Identifying 
individuals who present with a greater risk for developing hypertension may help target 
public health prevention efforts.  Risk scores used to predict incident hypertension in 
Caucasian populations incorporate measures of adiposity, parental history of hypertension 
and age.6, 128  Each of these factors contributes to hypertension onset.129  Older age and 
higher levels of BMI are well established risk factors for hypertension in Chinese and other 
populations,92, 130, 131 however, the interaction of parental history of hypertension with obesity 
has not been well examined and has largely been unexplored in Chinese.  
Parental history of hypertension is often collected in clinical and epidemiological 
settings, as it captures aspects of shared genetic and environmental factors that are associated 
with hypertension risk.  Research has shown a positive parental history of hypertension is 
associated with higher levels of systolic and diastolic blood pressure among offspring, as 
well as a greater risk of hypertension.74-77, 132-134  The correlation of blood pressure levels 
between parent and offspring has been observed across the life course, as early as at birth, 
and these associations between parent-child blood pressure levels have been shown to 
continue through adulthood.135, 136 
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The aggregation of blood pressure within families is attributed to interactions 
between shared genes and environments that result in physiologic and biochemical processes 
that contribute to increased blood pressure.72, 73  It is estimated that 30% to 60% of the inter-
individual variation in blood pressure is attributed to genetic factors.82, 83  Results from a 
Chinese sample showed that the proportion of observed variation in diastolic and systolic 
blood pressure that was attributed to genetic factors was 23% and 32%, respectively.122  In 
the same population, the correlation of blood pressure between either parent and child were 
0.16 for both systolic and diastolic pressure.122  Genes which may be passed from parent to 
child, such as variants in genes encoding angiotensin-converting enzyme, alpha-adducin and 
aldosterone synthase have been associated with higher systolic blood pressure in Chinese 
populations, and these genes may predispose individuals to hypertension, especially when 
coupled with a high sodium diet.137   
Epidemiologic studies that examine the effect of parental history of hypertension and 
BMI have found mean BMI levels among offspring with a positive parental history of 
hypertension were typically higher, by approximately 0.5 kg/m2 or more in Whites and 
Blacks 77, 80, 81, 138 and by 0.2 kg/m2 in Japanese76, compared to individuals with a negative 
parental history of hypertension.  The increased risk of hypertension associated with a 
positive family history in these ethnicities persists after adjustment for BMI.75, 76, 80, 81, 85    
Although individuals may develop hypertension for reasons unrelated to obesity, it is 
important to note that hypertension and obesity may share some common genetic and 
environmental risk factors. 139, 140  Yet it remains unclear if parental history of hypertension 
may modify the effect of BMI on hypertension and if the association varies by age.  Are 
individuals with a positive parental history of hypertension more susceptible to the effects of 
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obesity on blood pressure; or are individuals with a positive parental history of hypertension 
likely to develop prehypertension or hypertension regardless of their weight status, and 
therefore more resistant to the effects of obesity?  Also, do these relationships vary by age?  
The purpose of this paper is to investigate these questions in a population of Chinese adults. 
C. Methods 
1. Study population 
Data for this cross-sectional analysis were from the People’s Republic of China 
(PRC) Study, which examined a community based sample of Chinese men and women from 
urban and rural areas of Guangzhou and Beijing, China. Only data from Guangzhou were 
included here as young adults were not studied in Beijing.  Methods have been described 
previously.111  Urban participants were currently working or retired employees from eight 
workshops of the Guangzhou Shipyard Company and rural participants worked in 14 of the 
21 agricultural villages in the Dashi Township of Panyu County at the time of the 1981 
census.  Data were from (n=4,445) eligible subjects collected in 1983 from men and women 
aged 24–71 years at the urban and rural Guangzhou examination centers.  Participants were 
excluded if missing data on BMI (n=25), parental history of hypertension status (n=234), 
smoking (n=21) or alcohol (n=61).  Following these exclusions, 1,939 men and 2,165 women 
were included in the analyses.  The Institutional Review Board (IRB) at each field center 
approved this study, and the analysis was approved by the University of North Carolina at 
Chapel Hill IRB on research involving human subjects. 
2. Measurements 
The Collaborative Studies Coordinating Center at the University of North Carolina at 
Chapel Hill was responsible for protocols and training manuals for all measurements as well 
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as the review, processing, and analyses of all data.  Data were collected by trained personnel.  
Participants wore light clothing without shoes during collection of height, measured to the 
nearest centimeter (cm), and weight, measured to the nearest kilogram (kg).  Body mass 
index was calculated (weight (kg)/height (m)2).  
Blood pressure was measured three times using a random zero mercury 
sphygmomanometer on the right arm with the participant seated.  The average of the last two 
measurements was used in the analyses.  Blood pressure thresholds were based on the 
National High Blood Pressure Education Program Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.115   
Participants were classified as hypertensive if 1) systolic blood pressure was greater than or 
equal to 140 mmHg, 2) diastolic blood pressure was greater than or equal to 90 mmHg or 3) 
self-report of current antihypertensive medication use.  Participants who were free of 
hypertension were classified as pre-hypertensive if 1) systolic blood pressure was 120 to 139 
mmHg or 2) diastolic blood pressure was 80 to 89 mmHg.   
Demographic and lifestyle factors were collected with standardized interviewer 
administered questionnaires.  Cigarettes smoked per day (cig/day) were reported and alcohol 
consumed per day (grams/day) was derived from monthly alcohol consumption levels.  
Subjects reported highest level of education attained (less than senior middle school, senior 
middle school and greater than senior middle school).  Parental history of hypertension was 
determined based on self-report of whether a participant’s mother, father, both or neither 
parent had high blood pressure.  Subjects had the option to report “unknown” but this was 
not selected by any study participants.  Subjects were classified as having a positive parental 
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history of hypertension if hypertension was reported by at least one parent and negative if 
hypertension was not reported in either parent. 
3. Statistical analyses 
Our primary objective was to examine the association of BMI with prehypertension 
and hypertension and determine if this relationship varied by parental history of hypertension 
status and by age.  We found a significant (p=0.02) three way interaction between BMI, 
parental history of hypertension status, and age using the Wald test.  We also examined effect 
modification by sex using the Wald test with 1 degree of freedom, but this was not found 
(p>0.1).  Therefore, logistic models were stratified into 24-39 and 40-71 year age groups and 
included a BMI-parental history of hypertension interaction, with BMI in the continuous 
form.  We calculated the adjusted prevalence per 1,000 persons for BMI values 15-30 kg/m2 
and the prevalence difference per 1,000 persons using a BMI of 18.5 kg/m2, the lowest value 
within the range of the normal BMI category141, as the referent.  The “prvalue” command in 
Stata (Version 10.0) was used to calculate the prevalence and prevalence difference.  
Estimates were adjusted to the mean age, cigarettes, alcohol and distribution of gender and 
field center.103, 104  The delta method was used to calculate the standard errors and 95% 
confidence intervals for the prevalence and prevalence difference.        
D. Results 
 Characteristics of the 4,104 participants varied by age and by parental history of 
hypertension status (Table 5.1).  A positive parental history of hypertension was reported by 
18.6% of the study population.  In both age stratums, compared to subjects who reported a 
positive parental history of hypertension, subjects who reported a negative parental history of 
hypertension had slightly lower systolic and diastolic blood pressure, prevalence of 
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prehypertension and hypertension, BMI and education attainment but slightly higher 
consumption of alcohol and cigarettes.  This sample is quite thin as approximately one-fifth 
of the young adults and one-quarter of the older adults had a BMI less than 18.5 kg/m2.  For 
both age groups, BMI was positively associated with the prevalence difference for 
prehypertension and hypertension among both parental history groups (Figures 5.1-5.4).  
However, age-related differences in the associations of parental history of hypertension and 
BMI with prehypertension and hypertension were observed. 
Among young adults (24-39 years), the adjusted prevalence (95% CI) of 
prehypertension was similar regardless of parental history of hypertension.  For example, at a 
BMI of 18.5 kg/m2 the prevalence of prehypertension per 1,000 persons was 179 (157, 203) 
among subjects with a negative parental history of hypertension and 188 (140, 237) among 
subjects with a positive parental history of hypertension (Table 5.2).  The prevalence 
difference associated with an increase in BMI (Figure 5.1) was also similar or almost 
identical between subjects, regardless of parental history status.  However, when examining 
hypertension, parental history of hypertension was significantly associated with hypertension 
prevalence.  The prevalence of hypertension (95% CI) at a BMI of 18.5 kg/m2 was 
approximately four-fold greater among subjects who reported a positive parental history of 
hypertension (35 (15, 54) per 1,000 persons) compared to subjects who reported negative 
parental history (7 (3, 11) per 1,000 persons) (Table 5.2).  The adjusted prevalence difference 
associated with an increase in BMI above 18.5 kg/m2 was similar between subjects with a 
positive and negative parental history and almost identical within the underweight (<18.5 
kg/m2) and normal weight (18.5 - 24.9 kg/m2)  categories (Figure 5.2).141  This suggests, 
among young Chinese adults, a positive parental history of hypertension is associated with 
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greater hypertension risk among offspring but parental history status does not modify the 
prevalence difference of BMI with hypertension.   
In middle-aged (40 -71 years) adults, the adjusted prevalence (95% CI) of 
prehypertension per 1,000 persons at the reference level of BMI (18.5 kg/m2) was similar 
between subjects with a negative 277 (248, 307) and positive 297 (221, 374) parental history 
status (Table 5.2).  Although not significantly different, the prevalence difference for 
prehypertension associated with BMI tended to be greater among subjects with a positive 
parental history compared to those with a negative parental history (Figure 5.3).  Among the 
same age group, the adjusted prevalence of hypertension (95% CI) per 1,000 persons at the 
reference level of BMI (18.5 kg/m2) was also similar by parental history status; 77 (61, 94) 
for subjects with a negative parental history status and 61 (27, 96) for subjects with a positive 
parental history status (Table 2).  Although the baseline prevalence at the referent value was 
similar between groups, the prevalence difference for hypertension associated with BMI 
varied by parental history status (Figure 5.4).  Across BMI, even at values within the normal 
BMI range (18.5 - 24.9 kg/m2), the risk associated with BMI was greater among subjects 
with a positive parental history of hypertension.  The graded and steeper slope associated 
with a positive parental history was more apparent for hypertension compared to 
prehypertension. This suggests among middle-aged adults, parental history of hypertension 
alone is not associated with a greater risk of hypertension, but subjects with a positive 
parental history of hypertension are more sensitive to the effects of obesity as observed by 
the greater prevalence of hypertension associated with the prevalence difference for BMI. 
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E. Discussion  
Our goal was to determine the association of BMI with prevalent prehypertension and 
hypertension in Chinese adults and examine if this relationship differed by parental history of 
hypertension and by age.  In both age groups, BMI was positively associated with 
prehypertension and hypertension prevalence.  However, the association of parental history 
with prehypertension and hypertension prevalence was not consistent across age stratum.  In 
the young adults (24-39 years), a positive parental history was associated with a four-fold 
greater risk of hypertension but the effects of obesity on prevalence differences were similar 
across parental history groups.  In the middle-aged (40-71 years) group, the risk of 
prehypertension or hypertension was similar by parental history status, but subjects with a 
positive parental history of hypertension were much more susceptible to the effects of BMI 
as observed by the associations with the prevalence difference.  The trend was similar but 
weaker for prehypertension.  
When familial associations of blood pressure thresholds, such as hypertension are 
examined, studies in Caucasians have shown parental hypertension that develops before age 
60 is associated with a greater risk of hypertension in offspring, whereas onset of parental 
hypertension at 70 years or older, was associated with no greater risk of hypertension in 
offspring than that of the general population.75, 78  It is thought that hypertension that occurs 
much later in life is associated with weaker genetic and environmental factors that are less 
likely to be shared between parent and child.  One explanation as to why parental 
hypertension status was not related to hypertension onset in the middle-aged adults may be 
related to differences in age of hypertension onset among their parents.  However, we cannot 
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examine these associations as data related to the age of hypertension onset among subjects or 
their parents were not collected in this study. 
Few studies have explored the interaction of parental history of hypertension status 
and BMI with hypertension risk.  Examination of this relationship which included 
Caucasians and African Americans in the Atherosclerosis Risk in Communities Study 
(ARIC) indicated no effect modification of parental history status by BMI.79  A cross-
sectional study of 503 Swedish middle aged adults examined the independent and combined 
effects of parental history and obesity (a relative BMI % of >120%) status on the risk of 
hypertension.142  Compared to non-obese subjects with a negative parental history of 
hypertension, the odds ratios (95% CI), adjusted for age, sex and physical activity, were 3.0 
(1.1-8.0) for a positive parental history of hypertension, 4.8 (1.8, 13.0) for obesity and 9.1 
(4.1-20.1) for the joint effects of obesity and a positive parental history of hypertension.  
Another cross-sectional study which examined the independent and joint effects of obesity 
(BMI > 26 kg/m2) and family history of hypertension (in siblings and parents) on the risk of 
hypertension included a large Japanese sample (n=9,914).143  Odds ratios, adjusted for age, 
sex, smoking, alcohol and exercise, were graphed without confidence intervals.  The 
approximate values were 2.4 for obesity, 2.8 for a positive family history of hypertension and 
7.0 for their joint effects.  In both the Swedish and Japanese cohorts, the independent and 
joint effects of obesity and family history of hypertension were associated with a greater risk 
of hypertension compared to non-obese subjects with a negative parental history of 
hypertension.  Although the risks of their joint effects were larger than the sum of their 
independent effects, interactions between these factors did not appear statistically significant.    
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In 1979, a nationwide screening program of 720,000 U.S. Whites and Blacks found 
family history was independently associated with hypertension prevalence in both 20-39 and 
40-64 year old adults.  When self-report weight class was also considered, the prevalence of 
hypertension was three to four times greater among overweight individuals with a positive 
parental history status compared to normal weight individuals with a negative parental 
history of hypertension.  Excess cases of hypertension attributed to overweight among 
individuals with a positive parental history was 136 per 1,000 among 20-39 year olds and 
262 per 1,000 among the 40-64 year olds.  To our knowledge, no other studies on 
hypertension have reported results by weight and parental history of hypertension. 
Parental hypertension status was not validated in our sample and therefore, recall and 
information bias may be a problem.  Reports of positive parental history of disease have been 
linked to disease prevalence, access to care, family communication behaviors and health 
seeking behaviors.  These factors differ within and between populations.  Among Chinese 
adults, rates of hypertension awareness (44.7%), treatment (28.2%) and control (8.1%)40 are 
low compared to rates in the U.S. where rates of awareness (75.7%), treatment (65.1%) and 
control (36.8%) are much higher.32  If only about half of Chinese mothers and fathers who 
were hypertensive were aware of their hypertension, offspring reports of positive parental 
history status was most likely underestimated in our sample.  Results from U.S. studies 
suggest the sensitivity and specificity of self-report parental history of hypertension are fairly 
high, at 76% and 84%, respectively.144  These rates may not apply to our population.  A study 
of West Africans in Gambia 145 found subjects who reported a positive family history of non-
communicable disease were younger, more likely to live in a city, have higher education 
status and more likely to be female.  This was similar to our findings in which subjects 
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reporting a positive parental history tended to be younger, female, have higher education, and 
be from the urban center.   Most likely, when examining parental history status, this would 
bias our estimates towards the null.  As hypertension awareness changes across time, older 
individuals may be even less aware of a positive parental history of hypertension compared 
to younger generations.  
Although our sample was population based, subjects were from one region in 
southern China, Guangzhou.  Regional differences in the prevalence of hypertension within 
China have been observed.38, 39  Hypertension is less common in southern China, where diet 
and exercise patterns are substantially different from the north.  In addition, the prevalence of 
hypertension is lower in rural than urban areas, which has also been suggested to be related 
to higher levels of physical activity and lower levels of overweight.  Diet and physical 
activity patterns have evolved over time and dietary and physical activity patterns of previous 
generations may have protected individuals from developing hypertension. The surprising 
lack of association between parental history of hypertension and hypertension prevalence in 
the 40-71 year olds may in part be due to shifts in dietary and physical activity patterns or to 
other factors described above such as age-related differences in parental hypertension onset 
and hypertension awareness. 
It is important to note that health care has evolved in China.  Knowledge of 
hypertension among the parental generation may be close to actual rates of hypertension in 
that generation as access to health care was fairly egalitarian from 1949 to 1978.  During this 
time, the Chinese government operated the health system and provided equal access to health 
care regardless of the ability to pay.146   There was a strong emphasis on rural health, 
preventative medicine and community control of hypertension in many districts within 
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China.146, 147  Beginning in 1978, China’s health care system gradually shifted towards a 
market based approach whereby the government decentralized its power over the health care 
system and employers became a major supplier of health insurance.146   
Surveys on blood pressure and hypertension were conducted in many areas of China 
as early as 1958.147   A 1991 national blood pressure survey of adults aged 15-74 years in 
China found the prevalence of people with blood pressure levels of greater than or equal to 
140/90 mmHg were 17.1% in urban and 11.8% in rural areas.148  From earlier studies, 
hypertension prevalence rates were much higher in the older than younger age groups.  A 
survey from 1959 found the prevalence of hypertension among Chinese aged 50-59 years 
was 11.3% and among those 60-69 years the prevalence was 17.23%.147. These prevalence 
estimates in older adults are similar to the prevalence of positive parental history reported by 
our sample.  Middle-aged adults had a slightly lower prevalence of a positive parental history 
than young adults. Fewer cases of parental hypertension among middle-aged adults may also 
be due in part to previous definitions of hypertension which used higher cutpoints to define 
hypertension (>160/95 mmHg).  If parental hypertension represented more severe cases of 
hypertension, we would expect a stronger correlation of parental hypertension with offspring 
hypertension. 
Strengths of this work include the large population-based sample of Chinese, a group 
in which parental history of hypertension has largely been unexplored, use of measured 
anthropometrics and blood pressure and estimation using difference rather than ratio 
measures.120  The present study may be limited in that our analysis was cross-sectional and 
information regarding the age of hypertension onset among subjects were not collected.  It is 
possible that subjects in the 40-71 year age strata may have developed hypertension during 
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early adulthood.  Therefore, we cannot clearly separate the different findings between age 
stratums.  Additional limitations include a lack of dietary, physical activity or parental BMI 
data and use of self-report parental history of hypertension.  The relationship between 
parental history status, BMI and age may be clarified with a prospective cohort begun in 
early adulthood and collected validated measures of parental history status.  Hypertension 
and obesity are preventable risk factors for cardiovascular disease, which is a leading cause 
of death in China. The interaction of BMI and parental history of hypertension on 
hypertension prevalence has not been well studied and deserves further attention as this 
information could help inform public health efforts designed to identify individuals at risk of 
hypertension for prevention and early treatment. 
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Table 5.1. Demographic characteristics by age group and parental history of hypertension status 
 Young adults (24-39 years)  Middle-aged adults (40-71 years)  
Parental history of hypertension status Negative Positive  Negative Positive 
 (n=1,866) (n=474)  (n=1,473) (n=291) 
Age (years, mean (s.d.)) 32.2 (4.0) 32.6 (3.9)  49.7 (6.7) 46.6 (5.4) 
Gender (% women) 57.6 
 
50.4 
  
48.1  49.1 
 
Body Mass Index (kg/m2, mean (s.d.)) 20.1 (2.0) 20.4 (2.3)  20.2 (2.6) 21.0 (2.9) 
Parental history of hypertension (%)          
    Father   55.7     44.3  
    Mother   38.0     47.8  
    Both Parents   6.3     7.9  
Current cigarette or leaf smokers (%) 33.9  32.5   44.7  40.2  
Cigarettes or leaf smoked (cig/day, mean (s.d.)) 5.6 (9.4) 5.3 (8.9)  8.3 (12.0) 8.3 (12.0) 
Current drinkers (%) 21.9  13.9   26.1  18.9  
Alcohol consumed (g/day, mean (s.d.)) 10.8 (33.9) 6.7 (26.4)  17.7 (47.7) 11.4 (38.1) 
Educational attainment (%)          
     < Senior middle school 77.3 
 
56.8 
  
85.4  76.3 
 
     Senior middle school  13.7 
 
28.3 
  
5.0  10.0 
 
     > Senior middle school  1.8 
 
4.6 
  
1.2  4.8 
 
Field center (% urban) 43.0  75.5   44.9  69.1  
Systolic blood pressure (mmHg , mean (s.d.)) 110.3 (11.2) 113.0 (11.6)  115.9 (17.9) 119.7 (20.4) 
Diastolic blood pressure (mmHg, mean (s.d.)) 69.0 (8.8) 72.0 (9.2)  74.2 (10.4) 77.8 (11.4) 
Hypertension status (%)          
  Prehypertensive 22.8  25.3   27.7  29.2  
  Hypertensive 2.1  6.1   12.0  18.6  
Blood pressure medication use (%) 0.2  0.2   1.0  2.8  
Parental history of hypertension was positive if hypertension was reported for at least one parent and negative otherwise 
Prehypertensive was defined as non-hypertensive and systolic blood pressure of 120-139 mmHg or diastolic blood pressure 
of 80-89 mmHg and hypertensive defined as systolic blood pressure >140 mmHg, diastolic blood pressure >90 mmHg or 
self-report of current anti-hypertensive medication use 
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Table 5.2. Adjusted prevalence of prehypertension and hypertension per 1,000 persons (95% CI) at a BMI of 18.5 
kg/m2  by age group and parental history of hypertension  
             Young adults ( 24-39 years)               Middle-aged adults (40-71 years) 
        Negative                   Positive          Negative                              Positive 
 Prehypertension   179 (156, 203)  188 (140, 237)  277 (248, 307)  297 (221, 374) 
Hypertension 
 
7  (3, 11)  35 (15, 54)  77 (61, 94)  61 (27, 96) 
Models adjusted for age, alcohol, smoking, gender and field center. 
Parental history of hypertension was positive if hypertension was reported by at least one parent and negative otherwise 
Prehypertensive was defined as non-hypertensive and systolic blood pressure of 120-139 mmHg or diastolic blood 
pressure of 80-89 mmHg 
Hypertensive was defined as systolic blood pressure >140 mmHg, diastolic blood pressure >90 mmHg or self-report of 
current anti-hypertensive medication use 
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Figure 5.1.  Adjusted prevalence difference by BMI and parental history of hypertension status in Chinese young adults (24-39 
years) 
 
Adjusted to the mean age, cigarettes (smoked), alcohol consumed (g/day) and distribution of gender and field center.  
Prevalence differences were computed using a BMI of 18.5 kg/m2 as the referent. 
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Figure 5.2.  Adjusted prevalence difference for hypertension by BMI and parental history of hypertension status in Chinese 
young adults (24-39 years)  
  
 
 
 Adjusted to the mean age, cigarettes (smoked), alcohol consumed (g/day) and distribution of gender and field center.                  
Prevalence differences were computed using a BMI of 18.5 kg/m2 as the referent. 
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Figure 5.3.  Adjusted prevalence difference for prehypertension by BMI and parental history of hypertension status in 
Chinese middle-aged adults (40-71 years)  
 
 
Adjusted to the mean age, cigarettes (smoked), alcohol consumed(g/day) and distribution of gender and field center. 
Prevalence differences were computed using a BMI of 18.5 kg/m2 as the referent. 
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Figure 5.4.  Adjusted prevalence difference for hypertension by BMI and parental history of hypertension status in Chinese 
middle-aged adults (40-71 years)  
 
 
 
Adjusted to the mean age, cigarettes (smoked), alcohol consumed (g/day) and distribution of gender and field center. 
Prevalence differences were computed using a BMI of 18.5 kg/m2 as the referent. 
-200
0
200
400
600
800
1000
15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
P
r
e
v
a
l
e
n
c
e
 
d
i
f
f
e
r
e
n
c
e
 
p
e
r
 
1
,
0
0
0
 
p
e
r
s
o
n
s
BMI (kg/m2)
  
 
VI. THE ASSOCIATION OF HIP CIRCUMFERENCE WITH INCIDENT METABOLIC RISK 
FACTORS IN CHINESE, THE PEOPLE’S REPUBLIC OF CHINA STUDY    
A. Abstract
Studies in Caucasians have shown that after adjusting for waist circumference and 
body mass index (BMI), a larger hip circumference may be protective for metabolic risk 
factors.  The associations between adiposity and metabolic risk factors have been suggested 
to differ between Asian and Caucasian populations, yet to our knowledge, these associations 
have never been examined in a Chinese population.  Baseline (1987-88) and follow-up 
(1993-94) data were from the People’s Republic of China Study (n=1,144 men, n=1,776 
women). Logistic models were stratified by sex and adjusted for age, smoking, center, and 
education.  Incidence differences (ID) comparing the sex specific 85th percentile to the 15th 
percentile of hip were computed for elevated blood pressure, blood glucose and triglycerides, 
low HDL-C and multiple metabolic abnormalities (3 or more of the aforementioned).  In 
models adjusted for waist and BMI, the ID (95% CI) per 1,000 persons associated with a 12 
cm larger hip were -132 (-237, -26) for low HDL-C; -85 (-138, -31) for elevated 
triglycerides; and -49 (-83, -4) for multiple metabolic abnormalities. In males, a larger hip 
circumference was not associated with a reduction of incident risk factors although the ID 
tended to be negative.  In Chinese women, greater mass in the lower trunk region was 
protective for incident high triglycerides, low HDL-C and multiple metabolic abnormalities 
when adjusted for general and central adiposity.  This association was not detected in men.  
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Additional research is needed to better understand the mechanisms by which fat at different 
depots results in differential risk.  
B. Background 
Specific fat depots may be more closely related to metabolic risk than overall 
adiposity.149 Many studies have used the ratio of waist and hip circumferences as a means of 
capturing aspects of body shape that are poorly detected by BMI. Nevertheless, waist to hip 
ratio does not differentiate the independent effects of hip and waist circumferences and the 
ratio measure does not account for possible non-linear associations between the two 
anthropometrics.150, 151 
Although waist and hip are crude measures of adipose tissue distribution the 
circumference measures do show a high association with the size of the respective fat depots 
152, 153
, and they are clinically practical due to the low risk of assessments to patients, low cost 
and ease of collection. Waist circumference is an indicator of the amount of visceral and 
subcutaneous adiposity around the abdomen, while hip assesses skeletal frame size and 
adipose and muscle mass in the buttock and thigh regions (gluteofemoral) 154, 155. In mutually 
adjusted models, waist has been shown to correlate with abdominal visceral and 
subcutaneous adiposity and hip was inversely correlated with those depots but positively 
correlated with leg fat mass.155 Visceral and subcutaneous adipocytes have different lipolytic 
activities as visceral fat is associated with adverse cardiovascular risk factors and is more 
metabolically active compared with adipocytes in subcutaneous fat 153.  
In contrast to a large waist circumference at a given overall body size, a large hip 
circumference has been suggested to be less associated with risk of disease and even 
potentially protective. After adjustment for one another and for BMI, waist and hip 
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circumferences have been shown to have independent and opposite associations with 
cardiovascular risk factors, coronary heart disease (CHD), cardiovascular disease (CVD) and 
mortality.7-10, 87-89, 91, 153, 156-162 Studies examining components of hip and waist 
circumferences, specifically, leg and trunk fat and leg lean mass, using dual-energy X-ray 
absorptiometry (DXA) or computed tomography (CT) have found positive associations of 
trunk fat and inverse associations of thigh or leg fat with insulin resistance, dyslipidemia, 
diabetes and other metabolic risk factors. These associations have been observed in Black, 
White and Japanese populations.155, 161, 163-166 A recent review has summarized some of the 
mechanistic evidence related to gluteofemoral body fat and metabolic health.167 Differential 
effects by BMI category and by gender have been reported. 161, 166, 168 The attenuation of risk 
associated with proportionally greater leg fat mass is more frequently observed in overweight 
and obese individuals than in normal weight individuals and is more often observed in 
women than in men.161, 166, 168     
To our knowledge, no studies have evaluated the association of hip circumference 
(HC), independent of waist circumference or BMI, with cardiovascular risk factors in a 
Chinese population. It is well established that adiposity is associated with metabolic disease 
risk. As Chinese have greater adiposity at the same level of BMI compared to non-Asian 
populations and experience metabolic abnormalities at low levels of adiposity,92, 169 it is 
uncertain whether a protective effect of hip would be observed in a Chinese population. Our 
goal was to explore whether a larger hip circumference, when controlling for waist 
circumference or BMI, would be associated with a lower incidence of metabolic risk factors 
in a Chinese cohort from Guangzhou, China.  
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C. Methods 
1. Study population 
Data for this work are from the community-based People’s Republic of China (PRC) 
Study.111  Waist and hip circumferences were collected from PRC respondents who lived in 
the urban and rural areas of Guangzhou, China (southern). Baseline and follow-up 
examinations were in 1987-1988 and 1993-1994, respectively. Participants were aged 28–69 
years at baseline.  
Of the n=3,019 eligible subjects, participants were excluded if missing 
anthropometric data at baseline (n=52) or follow-up (n=15), missing education at baseline 
(n=1), self-report of cancer (n=13) or CHD (n=18). Following these exclusions, 1,144 men 
and 1,776 women were included in the analyses. For each of the incident outcomes 
examined, prevalent cases of the condition were excluded. This study was approved by the 
IRB at each field center, and the analysis was approved by the University of North Carolina 
at Chapel Hill Institutional Review Board on research involving human subjects.    
2. Measurements 
Protocols and training manuals for all measurements as well as the review, 
processing, and analyses of all data were administered by the Collaborative Studies 
Coordinating Center at the University of North Carolina at Chapel Hill. Data were collected 
in examination centers by trained personnel. Participants wore light clothing without shoes 
during collection of anthropometric data. Height was measured to the nearest centimeter (cm) 
and weight to the nearest kilogram (kg). Body mass index was calculated from these 
measures (weight (kg)/height (m)2). Circumferences of the waist and hip were measured to 
the nearest 0.1 cm. Waist was measured by passing the tape measure through the midpoint 
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between the superior iliac crest and the lowest rib. Hips were measured at their maximum 
protrusion. 
Subjects were instructed to fast 12 hours prior to the examination. All glucose assays 
were performed on an Abbott autoanalyzer. Serum glucose was measured by the 
hexokinase/glucose-6-phosphate dehydrogenase method. High-density lipoprotein 
cholesterol (HDL-C) and triglycerides (TG) were measured according to standardized 
protocols by the Lipid Standardization Program of the U.S. NHLBI and CDC. Serum TG was 
determined with use of an enzymic reagent from Abbott Laboratories.  Serum HDL was 
measured using the Boehringer Mannheim Diagnostics high-performance enzymic reagent 
calibrated with precise standards on the Abbott analyzer after precipitation of other lipid 
fractions with dextran sulfate.  To ensure quality control, random samples were analyzed by 
the CDC.  
Blood pressure was measured three times at each visit using a random zero mercury 
sphygmomanometer on the right arm with the participant seated.  The average of the last two 
measurements is used in the analyses.  Participants self-reported use of hypertension 
medications in the previous two weeks.   
Outcomes were dichotomized based on criteria from the Adult Treatment Panel III 
(ATP III) of the National Cholesterol Education Program for metabolic syndrome.170 
Components of the metabolic syndrome were defined as: 1) HDL-C less than 1.03 mmol/L in 
males or less than 1.29 mmol/L in females, 2) triglycerides of 1.7 mmol/L or higher, 3) 
fasting blood glucose of 5.6 mmol/L or higher or self-reported diabetes and 4) blood pressure 
greater than or equal to 130/85 mmHg or self-report of current antihypertensive medication 
use. The fifth criterion of the metabolic syndrome is a large waist circumference. Since waist 
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circumference was included as a covariate in our models we did not model it as an outcome. 
Instead we assessed a clustering of risk factors similar to the ATP III metabolic syndrome 
definition but exclusive of waist circumference, which we termed “multiple metabolic 
abnormalities” and defined as the presence of at least three of the four aforementioned ATP 
III outcomes examined. 
3. Statistical analyses 
Models were stratified by gender because of the well known differences in body 
shape between men and women.171 Dichotomous outcomes were coded as 0 (no disease) or 1 
(incident disease). All models include the covariates field center (urban or rural), age (years), 
and highest education level attained (less than senior middle school, senior middle school and 
greater than senior middle school). For all outcomes, the covariates for smoking, alcohol, 
menopausal status and physical activity were examined but were not included because 
associations were small, not statistically significant (p<0.05) and did not influence the 
coefficients associated with variables of interest. 
Quadratic terms were tested to assess non-linear associations of BMI, waist, hip and 
age with metabolic risk factors. Most quadratic terms were not significant at p<0.05, except 
for age2, which improved model fit significantly in women. Interactions between hip and age 
as well as hip and BMI, were assessed for each risk factor outcome using the Wald test with 
1 degree of freedom and none were significant at p<0.05. The adjusted incidence at the sex 
specific 15th percentile of hip and the incidence differences (ID) comparing the sex specific 
85th percentile to the 15th percentile of hip were computed. ID estimates were obtained from 
logistic regression models and 95% confidence intervals (CI) were calculated using the delta 
method by the prvalue command in STATA 10.0. The incidence and ID were also modeled 
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with adjustment for additional anthropometric measures (waist and BMI). The ID was 
standardized to the mean covariate values for continuous variables and to the most prevalent 
education level (< senior middle school) and center (rural).        
D. Results 
 The distribution of most demographic characteristics was similar between the sexes, 
except for alcohol and smoking status (Table 6.1). A small percentage of women consumed 
alcohol (15.1%) or smoked (3.0%), whereas, men were much more likely to drink (59.4%) or 
smoke (66.1%). The majority of subjects were normal weight or underweight and did not 
have abdominal obesity according to standard WHO BMI definitions and Asian central 
obesity cutpoints of >90 cm in males and >80 cm in females (Table 6.1). Anthropometric 
measures tended to be highly correlated. In this sample, Pearsons’ correlation coefficients for 
waist, hip and BMI were high and ranged from 0.76 to 0.83 in men and 0.79 to 0.87 in 
women. Despite the high correlations, collinearity of anthropometric measures, evaluated 
using a variance inflation factor (VIF) were all less than 5.0, well below the criterion for 
indication of 10.0. 
The unadjusted baseline prevalence and six-year incidence for each outcome are 
shown in Table 6.2. In both women and men, multiple metabolic abnormalities and elevated 
blood glucose were the least prevalent outcomes (<10%); however, the crude prevalence and 
incidence levels were higher, between 10% and 34%, for elevated blood pressure, low HDL-
C and elevated triglycerides. The adjusted incidences of metabolic risk factors at the 15th 
percentile of hip circumference are shown in Table 6.3 and the incidence difference (between 
the 85th and 15th percentile of hip (a difference of 11 cm in males and 12 cm in females)) per 
1,000 persons are shown in Figures 6.1 and 6.2.  Hip was positively associated with incident 
 83 
 
outcomes when it was the only anthropometric measure included in the model (model 1). 
When adjusted for waist (model 2) or BMI (model 3), the ID tended to be null or negative, 
suggesting hip circumference may be neutral or inversely associated with incident metabolic 
risk factors when accounting for general or central adiposity. In women (Figure 6.1), with 
adjustment for waist circumference, a larger hip circumference was associated with a 
significant decrease in incidence (95% CI) per 1,000 persons for high triglycerides -74 (-120, 
-27) and low HDL cholesterol -114 (-207, -21); and when adjusting for BMI, hip 
circumference was associated with a significant decrease in incidence per 1,000 persons for 
high triglycerides -56 (-108, -4) and multiple metabolic abnormalities -37 (-69, -5). In males 
(figure 6.2), ID estimates for models 2 and 3, tended to be null or negative.  
Model 4, included hip and was adjusted for both waist and BMI. In women, the ID 
(95% CI) per 1,000 persons was -85 (-138, -31) for incident high triglycerides, -132 (-237, -
26) for low HDL-C and -49 (-83, -14) for multiple metabolic abnormalities. For blood 
pressure and glucose, estimates were negative but confidence intervals included zero. In men, 
point estimates for all the outcomes examined were negative and the confidence intervals 
included zero. 
E. Discussion 
In this prospective study, hip circumference was positively associated with incident 
metabolic risk factors in Chinese men and women. After adjustment for waist circumference 
and BMI, women with a larger hip circumference had a lower risk of incident elevated 
triglycerides, low HDL-C and multiple metabolic abnormalities and null associations were 
found for elevated blood pressure and elevated glucose. In men, after adjustment for waist or 
waist and BMI, the association of hip circumference with glucose, lipid levels and multiple 
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metabolic abnormalities was inverse but not statistically significant. Weaker protective 
associations in men are consistent with other studies, many of which found stronger evidence 
of an inverse association of hip with adverse outcomes in women.156-158, 160, 172 This 
differential may be due to gender differences in hip girth, body composition, and/or fat 
distribution. Although the gender differences in hip circumference are smaller in Chinese 
compared to Caucasians, gender differences in body shape and fat distribution persist.173 In 
this cohort, the difference in hip circumference between women and men was less than 1 
centimeter, whereas, most studies in Caucasian populations have shown gender differences in 
hip circumference between 1 and 6 centimeters.9, 88, 155 We explored whether gender 
differences were related to differences in height but when height was added to the models, 
the estimates remained essentially unchanged.  
The participants in our study were leaner than populations examined in previous 
studies of hip circumference, yet associations between hip and metabolic risk factors were 
observed. Here the mean BMI among Chinese was 20.6 kg/m2 in men and 21.0 kg/m2 in 
women and fewer than 6% of men and 10% of women had a BMI of 25 kg/m2 and above, 
whereas, in most studies that examined the risk factor associations with hip the mean BMI 
was > 25 kg/m2.7-10, 87-91, 172 The sex specific mean value of hip in our population was also 
smaller than means reported in previously published studies.7-10, 87-91, 172 For example, a 
recent study 172 that reported an inverse association of hip circumference with incident 
diabetes and CHD included data from American Whites and Blacks in whom the mean value 
for hip circumference within the lowest quintile of hip (92.7 cm) was larger than our overall 
population mean for hip (87.8 cm).  
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We know of six studies that have used a cross-sectional design to examine the 
association of hip circumference with metabolic syndrome or its component risk factors 
(blood pressure, lipids and glucose).9, 89-91, 156, 157, 161 Two of these studies were conducted 
among Australians.89, 91 Dixon, et al.,91 examined obese Australian women and used receiver 
operating characteristic (ROC) curves to identify the values of hip and waist circumferences 
associated with the highest sum of sensitivity and specificity for the presence of metabolic 
syndrome. They then tested the odds of metabolic syndrome above versus below that cutoff. 
The investigators found a small hip circumference (below the cutoff of 115 cm) was 
associated with greater odds of the metabolic syndrome (OR (95% CI): 12.3 (3.0, 51.0)) 
compared to a large hip circumference (above the cutoff of 115 cm). A small hip 
circumference was also found to be a stronger predictor of the metabolic syndrome than a 
large waist circumference (above the cutoff of >100 cm) (OR (95% CI): 5.2 (1.4, 20.0)). The 
Australian Diabetes, Obesity and Lifestyle study 89, a nationally representative study among 
11 247 participants aged 25 and older, found that the OR (95% CI) associated with a 1 
standard deviation (SD) increase in hip (7.6 cm in men and 11.1 cm in women) was 0.55 
(0.41, 0.73) in men and 0.42 (0.27, 0.65) in women for diabetes; 0.58 (0.50, 0.67) in men and 
0.37 (0.30, 0.45) in women for dyslipidemia; and 0.80 (0.69, 0.93) in men and 0.88 (0.70, 
1.11) in women for hypertension. 
The Quebec Family Study examined the association of hip with metabolic risk factors 
by modeling hip as a continuous variable.9 Models were adjusted for age, BMI, and waist 
circumference. In men, a 1 centimeter increase in hip was associated with higher levels of 
HDL cholesterol (mean + SD: 0.008 + 0.004 mmol/L) and lower levels of triglycerides (-
0.039 + 0.011 mmol/L) and glucose (-0.039 + 0.018 mmol/L). Although not significant, hip 
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was positively associated with systolic (0.310 + 0.233 mmHg) and diastolic (0.127 + 0.144 
mmHg) blood pressure. In women, the association of a 1 cm increase in hip with HDL 
cholesterol (0.005 + 0.003 mmol/L), triglycerides (-0.017 + 0.006 mmol/L) and glucose (-
0.002 + 0.011 mmol/L) were similar in direction to what was observed for men, but only the 
association of hip with triglycerides was significant. Both systolic (-0.222 + 0.125 mmHg) 
and diastolic (-0.086 + 0.079 mmHg) blood pressure were inversely related to hip, although 
not significantly (p>0.05).  
Two papers summarized results from a cross-sectional study of Caucasians in Tehran, 
Iran.156, 157 Investigators examined the association of hip circumference with components of 
the metabolic syndrome in 5,720 women 156 and 4,040 men 157 aged 18-74. Quintiles of hip 
circumference were used to predict the odds ratio (OR) for metabolic syndrome components 
as defined by the ATP III guidelines. In women, the adjusted OR (95% CI) comparing the 
largest versus smallest hip quintile was inversely associated with all components of the 
metabolic syndrome and in men this was true for all outcomes except elevated blood pressure 
(1.06 (0.67, 1.68)). Models were adjusted for age, smoking, physical activity, BMI, height 
and waist. In women, the adjusted OR (95% CI) comparing the largest (>110 cm) versus 
smallest (<95 cm) hip quintile were 0.74 (0.52, 0.97) for high triglycerides, 0.56 (0.40, 0.78) 
for low HDL cholesterol, 0.48 (0.30, 0.78) for abnormal glucose and 0.61 (0.43, 0.90) for 
elevated blood pressure. In men, the adjusted OR (95% CI) comparing the largest (>102 cm) 
versus smallest (<90 cm) hip quintile was 0.73 (0.47, 0.93) for high triglycerides, 0.91 (0.83, 
0.96) for low HDL cholesterol, 0.36 (0.19, 0.70) for abnormal glucose and 1.06 (0.67, 1.68) 
for elevated blood pressure. 
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A cross-sectional study that examined the association of hip circumference with 
metabolic risk factors in non-Caucasians included Melanesians, Micronesians, Indians and 
Creole from Mauritius, Rodrigues, Papua New Guinea and Nauru.90 In all four ethnic groups 
studied, a 1 standard deviation larger hip circumference (6.9-11.8 cm in men and 9.7-13.6 cm 
in women) was associated with lower glucose and triglyceride levels in both sexes and higher 
HDL levels in women only, after adjustment for waist circumference, BMI, and age. Among 
men and women the adjusted standardized beta coefficients associated with 1 standard 
deviation larger hip ranged from -0.56 to -0.11 mmol/L for triglycerides, -0.01 to 0.43 
mmol/L for HDL and -0.38 to 0.05 mmol/L for glucose. There was an inverse trend of hip 
with systolic blood pressure for all female ethnic groups and for three male ethnic groups, but 
none were statistically significant. An inverse association of hip with diastolic blood pressure 
was observed in few ethnic groups and none were significant.  
To our knowledge the only other study of hip that included a large East Asian sample, 
used anthropometry and DXA to examine the cross-sectional association of hip 
circumference and depots of lean and fat mass with cardiovascular risk factors.161 
Participants included Japanese men (n=1 249) and women (=3 007) aged 20-79 years. A 1 
centimeter increase in hip circumference was associated with a decrease in the odds ((OR 
(95% CI) for males and for females) of hypertension (0.92 (0.87, 0.98))and (0.94 (0.91, 
0.98)) low HDL-C (0.91 (0.84, 0.98)) and (0.88 (0.81, 0.95)), hypertriglyceridemia (0.91 
(0.87, 0.96)) and (0.97 (0.93, 1.01)), dyslipidemia (0.92 (0.87, 0.96)) and (0.96 (0.93, 0.98)), 
and diabetes (0.88 (0.79, 0.97)) and (0.90 (0.84, 0.98)) when controlling for BMI and waist. 
Further examination of cardiovascular risk factors with measures of body composition 
suggested a positive association of trunk fat mass and a negative association of leg fat mass 
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with hypertension, hypertriglyceridemia, dyslipidemia and diabetes in men. In women, 
greater trunk fat mass and lower leg fat mass were significantly and positively associated 
with these outcomes as well as for hypercholesterolemia and low HDL-cholesterol.  
The 6 cross-sectional studies presented above support the inverse association of a 
larger hip with metabolic risk factors when controlling for waist or BMI. The reduction in 
risk was generally moderate with odds ratios typically in the range of 0.9 to 0.4 for a one 
standard deviation increase in hip circumference or for comparison of the highest to lowest 
quartile or quintile of hip. Similar to our study of incidence, the majority of these studies of 
prevalence 9, 89, 90, 157 found weaker associations of hip with blood pressure, compared to the 
association with other metabolic risk factors. Hypertension is a multi-genic disease that 
varies in etiology 44; therefore, it is possible that only a subset of individuals with 
hypertension have elevated blood pressure as a result of mechanisms related to fat 
distribution.  
To our knowledge, our study is the first to examine the prospective association of hip 
with all metabolic syndrome components. Longitudinal studies examining the associations 
with hip have focused on CHD, CVD, diabetes or mortality as outcome measures and none 
included an East Asian sample. We know of six studies that have examined longitudinal 
associations with hip,7, 8, 87, 88, 162, 172 all of which support the protective effect of a larger hip 
circumference on incident CHD, CVD, diabetes and mortality when controlling for central or 
general adiposity. We will briefly summarize results from three 87, 88, 172 of those studies that 
include glucose or diabetes as an outcome measure, as those results are more closely related 
to the present study.  
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A study of the Hoorn cohort from the Netherlands included 1,357 Dutch men and 
women aged 50-75 years over eight years of follow-up.88 A 1 standard deviation larger hip 
(5.1 cm in men and 6.9 cm in women) was associated with a lower risk of incident type 2 
diabetes, independent of BMI, age, and waist circumference. The relative risk (95% CI) for 
incident type 2 diabetes associated with a 1 standard deviation change in hip were 0.55 (0.36, 
0.85) in men and 0.63 (0.42, 0.94) in women. Further exploration of the association of a 1 
standard deviation of hip at baseline with fasting glucose concentrations at follow-up were -
0.178 (mmol/L) (p=0.005) in men and -0.154 (mmol/L) (p=0.008) in women after adjustment 
for age and BMI.  
A study of 1,405 Swedish women aged 38-60 examined the association of hip with 
mortality and 24-year incidence of myocardial infarction, combined cardiovascular diseases 
and diabetes.87 Increasing quartiles of hip (cutpoints were 94.5, 98.5 and 103.5 cm) were 
associated with fewer cases of each outcome examined. The proportional hazard ratio 
comparing the highest to lowest quartile of hip were 0.31 (0.12, 0.80) for diabetes, 0.43 
(0.23, 0.82) for cardiovascular disease, 0.34 (0.14, 0.79) for myocardial infarction and 0.59 
(0.35, 0.99) for total mortality after adjustment for age, smoking, BMI and waist. When hip 
was modeled continuously (as residuals regressed with BMI), an inverse association for 
larger hip was reported for all outcomes examined. 
The association of hip circumference with incident diabetes and CHD was examined 
in a biracial cohort of 10,767 Black and White men and women from the United States of 
America ARIC cohort. 172 Successive quintiles of hip were associated with reduced hazard of 
diabetes (hazard ratios=1.00, 0.92, 0.77, 0.67, 0.72) when adjusted for waist, age, race, 
gender and study center. When models were additionally adjusted for BMI, the trend was 
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stronger (p<0.001) as the hazard ratios were 1.00, 0.75, 0.56, 0.41 and 0.37. Similar trends in 
hazard ratios across successive hip quintiles were observed for diabetes when models were 
stratified by gender or by race; however, the trends were statistically significant for women 
and for Whites only. Both of these groups had a larger sample size than the non-significant 
alternative. Race and sex stratified estimates were not reported for CHD. However, in models 
that examined CHD in the full sample, the hazard ratios associated with successive quintiles 
of hip were 1.00, 0.92, 0.75, 0.63 and 0.50 when adjusted for waist, age, race, sex and center 
and 1.00, 0.83, 0.62, 0.49 and 0.37 with additional adjustment for BMI.   
Overall, results from both cross-sectional and longitudinal studies support a 
protective effect of a larger hip circumference with glucose, lipids and health outcomes 
(CHD, CVD, mortality) and perhaps a weak association with blood pressure. Although the 
causal mechanisms between fat depots and risk factors are not certain, it has been suggested 
that inflammatory markers and insulin resistance may play an intermediary role in the link 
between adipose tissue and metabolic risk.149, 167 Adipose tissue in the gluteofemoral region 
may serve an important role in the removal of non-esterified fatty acids (NEFA) from the 
circulation.174 This activity could protect the liver, pancreas and skeletal muscle from 
exposure and accumulation of NEFA and thereby limit the development of insulin resistance. 
Two recent studies examined the influence of regional fat, using DXA 166 or computerized 
tomography (CT) 175, on insulin resistance and inflammatory markers in non-Asian samples. 
A study using DXA examined the influence of regional fat on insulin resistance in obese 
Norwegian Caucasians. Among subjects with a similar BMI, leg fat was inversely correlated 
with fasting glucose, fasting insulin, homeostasis model assessment of insulin resistance 
(HOMA-IR) and total cholesterol in women but neutral in men.166 A second study 175 
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included Black and White men and women from the U.S.A. based Dynamics of Health, 
Aging and Body Composition (Health ABC) study to examine the association of body 
composition, measured using CT scans, with the inflammatory markers C-reactive protein 
(CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Differences in fat 
distribution were found across gender and race yet in all race and gender groups, abdominal 
visceral adiposity was most associated with an adverse profile of inflammatory markers, 
higher interleukin-6 (IL-6) and C-reactive protein (CRP) (p<0.05). Conversely, thigh 
subcutaneous fat was associated with a trend toward lower inflammatory marker 
concentrations, when adjusted for thigh intermuscular fat, BMI, age and other covariates. 
However, it was significantly (p<0.05) associated with lower IL-6 and TNF-α in white men 
only. Thigh subcutaneous fat has also been correlated with greater insulin sensitivity.176 More 
research is needed to better understand the underlying mechanisms in various populations. 
This is the first longitudinal study to indicate beneficial effects of a large hip 
circumference on incident metabolic outcomes in a Chinese population. This population was 
unusually lean by Western standards, indicating that high levels of adiposity are not required 
in order for protective effects of hip to be detected. Strengths of this work include the quality 
control of the data collection and longitudinal design and use of measured anthropometry. 
This study is limited in that we did not have more discriminative measures of body 
composition such as DXA or CT scans; the sample is from one city in southern China during 
1987-94 and the prevalence of obesity has increased since this time. Further examination of 
hip circumference with metabolic abnormalities in epidemiologic studies may help clarify the 
underlying pathology and differences observed across body weight categories and gender. 
Additional research on Chinese populations that incorporates subjects who are overweight 
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and obese and includes additional measures of trunk and leg fat and leg lean mass may 
provide insight into the mechanistic role of regional adiposity on metabolic risk factors. 
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*
 Central obesity is defined as a waist circumference > 90 cm in males and > 80 cm in 
females, according to the World Health Organization (WHO) guidelines for Asians.
Table 6.1. Baseline characteristics 
    
 Women  Men  
Variables (n=1 776)  (n=1 444)   
Age (years), mean (s.d.) 44.8 (8.0)  45.1 (8.3)  
Body Mass Index (kg/m2), mean (s.d.) 21.0 (2.8)  20.6 (2.5)  
Body Mass Index Category (%)       
    <18.5 kg/m2 18.2   18.9   
    18.5-< 23.0 kg/m2 62.6   65.4   
    23.0-<25.0 kg/m2 10.8   10.1   
    25.0-<27.5 kg/m2 5.9   4.3   
    27.5-<30.0 kg/m2 1.7   1.1   
    30.0-<32.5 kg/m2 0.5   0.4   
Waist circumference (cm), mean (s.d.)  70.5 (7.8)  73.2 (7.6)  
Central obesity* (%)  13.4   3.4   
Hip circumference (cm), mean (s.d.) 88.1 (6.3)  87.4 (5.4)  
Hip circumference, 15th percentile (cm)  82.0    82.0   
Hip circumference, 85th percentile (cm) 94.0    93.0   
Current cigarette or leaf smokers (%) 3.0   66.1   
Current drinkers (%) 15.1   59.4   
Educational attainment (%)           
     < High school 82.2   79.0   
     High school  14.6   17.6   
Center (rural) (%) 56.6   59.7   
Systolic blood pressure (mmHg), mean (s.d.) 112.1 (15.8)  113.3 (14.8)  
Diastolic blood pressure (mmHg), mean (s.d.) 72.0 (9.5)  73.6 (9.9)  
Glucose (mmol/L), mean (s.d.) 4.4 (1.1)  4.1 (0.9)  
HDL cholesterol (mmol/L), mean (s.d.) 1.4 (0.3)  1.4 (0.4)  
Triglycerides (mmol/L), mean (s.d.) 1.3 (1.0)  1.3 (1.1)  
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Table 6.2.  Crude baseline prevalence and 6-year incidence of metabolic abnormalities among Chinese women and men 
 Women  Men 
 Prevalence   Incidence  Prevalence   Incidence 
 %   %   %   % 
Elevated blood pressure (>130/85 mmHg or medication)     15.2   23.6   17.2     30.2 
Elevated glucose (>5.6 mmol/L)       9.6   13.1   7.5       8.6 
Low HDL-C (<1.03 mmol/L in males; <1.29 mmol/L in females)     34.3   32.8       15.0     13.3 
Elevated triglycerides (>1.7 mmol/L)     23.9   11.1       22.1     15.8 
Multiple metabolic abnormalities (>3 of the above criteria)       5.0     8.8   2.4       6.1 
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Table 6.3.  Adjusted incidence of metabolic abnormalities per 1 000 persons (95% CI) at the 15th percentile of hip 
circumference 
       Model 2  Model 3  Model 4 
Risk at the 15th percentile of 
hip1 (95% CI) Model 12   
(Model 12 + 
waist)  
(Model 12 + 
BMI)  
(Model 12 + 
waist + BMI) 
Women        
Elevated blood pressure  
(>130/85 mmHg or medication) 191(161, 220)  237 (194, 281)  233 (188, 278)  246 (198, 294) 
Elevated glucose (>5.6 mmol/L) 96 (75, 117)  122 (90, 155)  115 (82, 147)  123 (88, 158) 
Low HDL-C (<1.29 mmol/L) 295 (257, 334)   380 (323, 437)   366 (306, 427)  389 (326, 453) 
Elevated triglycerides  
(>1.7 mmol/L) 75 (56, 95)  128 (92, 163)  120 (84, 156)  135 (95, 176) 
Multiple metabolic abnormalities  
(>3 of the above criteria) 42 (29, 55)   70 (46, 93)   74 (49, 100)  81 (53, 110) 
        
Men        
Elevated blood pressure  
(>130/85 mmHg or medication) 220 (183, 258)  274 (219, 328)  279 (225, 333)  292 (233, 350) 
Elevated glucose (>5.6 mmol/L) 56 (37, 75)  86 (51, 121)  84 (52, 117)  95 (56, 134) 
Low HDL-C (<1.03 mmol/L) 87 (63, 110)   138 (95, 180)   124 (85, 162)  144 (99, 190) 
Elevated triglycerides  
(>1.7 mmol/L) 
112 (84, 141) 
  
179 (129, 228) 
 
150 (107, 193)  182 (130, 234) 
Multiple metabolic abnormalities  
(>3 of the above criteria) 
21 (11, 31) 
  
47 (24, 71) 
 
40 (20, 59)  53 (26, 80) 
1The 15th percentile of hip is 82 cm in men and in women 
2Model 1 includes hip, age, smoking, center and education. For women, this model also includes age2 
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Figure 6.1.  Incidence difference (95% CI) per 1,000 persons for metabolic abnormalities at the 15th versus 85th percentile of 
hip circumference in women 
 
 
Models were adjusted for baseline age, age2, education level, smoking status and field center. Multiple metabolic abnormalities was 
defined as the presence of three or more metabolic abnormalities (elevated blood pressure, elevated glucose, low HDL-C and elevated 
triglycerides). The 15th and 85th percentiles of hip were 82 cm and 94 cm, respectively. 
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Figure 6.2.  Incidence difference (95% CI) per 1,000 persons for metabolic abnormalities at the 15th versus. 85th percentile of 
hip circumference in men 
 
 
 
Models were adjusted for baseline age, age2, education level, smoking status and field center. Multiple metabolic abnormalities was 
defined as the presence of three or more metabolic abnormalities (elevated blood pressure, elevated glucose, low HDL-C and elevated 
triglycerides). The 15th and 85th percentiles of hip were 82 cm and 94 cm, respectively. 
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VII. SYNTHESIS 
A. Overview 
The goal of this work was to better understand the association of body weight and 
circumference measures with metabolic risk factors in Chinese Asians.  For Aim 1, we 
examined the ethnic-specific association of BMI with incident hypertension for Chinese 
Asian, American White and American Black during young and middle adulthood.  For Aims 
2 and 3, our analyses focused exclusively on the Chinese Asian population.  We wanted to 
investigate associations of adiposity which have been explored in Caucasian but not Chinese 
populations.  Since the relationship of adiposity with metabolic risk factors may vary across 
ethnic groups, it was important to evaluate these associations in Chinese.  Specifically, our 
focus for Aims 2 and 3 were the influence of parental history of hypertension status and hip 
circumference on metabolic risk factors.  
Our sample of Chinese Asians from the PRC cohort was a very lean population.  
Approximately 90% of subjects were normal weight or underweight and few subjects were 
obese by WHO (>30 kg/m2) or Chinese (>28 kg/m2) standards.   However, despite the 
leanness of our Chinese Asian sample, we found significant associations between measures 
of adiposity with metabolic risk factors.  For Aim 1, the association of BMI with the 
incidence difference for hypertension was strongest during young and middle adulthood for 
Chinese Asians compared to American Blacks and American Whites.  This was surprising, 
considering American Blacks had a higher prevalence and incidence of hypertension as well 
as much higher mean BMI compared to Chinese Asians.  Yet, despite these differences 
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between ethnicities, the association of BMI with hypertension was not as strong among the 
American Blacks as that observed for the Chinese population.  In both American Blacks and 
Whites the association of BMI with the incidence difference for hypertension increases 
gradually across the BMI range for both young and middle-aged adults.  However, for 
Chinese Asians, the association of BMI with the incidence difference for hypertension 
increased exponentially beginning at a BMI of 23 kg/m2 in young adulthood.  During middle 
adulthood, the association of BMI with the incidence difference for hypertension was steep 
across the full BMI range examined for Chinese.   Based on our findings Chinese Asians 
appeared to be more sensitive to the effects of BMI for hypertension incidence.  American 
Blacks may therefore experience high levels of hypertension due to additional factors beyond 
obesity which were unmeasured in our sample such as diet, physical activity, stress and 
genetic factors.   
Aim 2 expanded upon the results from Aim 1, by exploring effect modification of the 
BMI-hypertension relationship by parental history of hypertension status and by age.  Little 
is known about parental history of hypertension status in Chinese and few studies have 
examined the interaction of BMI, parental history of hypertension and age in any ethnic 
group.  Results varied between the young and middle-aged Chinese populations.  This was 
not surprising, considering the literature suggests age modifies the association of parental 
history of hypertension status with hypertension onset in offspring.  We found that during 
young adulthood, both BMI and parental history of hypertension status influenced 
hypertension risk.  However, interactions between BMI and parental history status were not 
detected.  During middle adulthood, parental history status alone did not influence 
hypertension risk.   However, effect modification of the BMI-hypertension association by 
 100 
parental history status was quite strong.  In the middle-aged group, a positive parental history 
of hypertension was associated with a greater sensitivity to BMI.  The following limitations 
of these analyses are worth mentioning; parental history status was not validated in our 
sample and we did not have measures of parental hypertension onset, which has been shown 
to influence hypertension risk in off-spring.  Therefore, it is difficult to ensure if our results 
are truly reflective of the underlying associations.  
For Aim 3, the focus shifted from overall to regional depots of adiposity.  Although 
greater levels of abdominal adiposity have been shown to be deleterious, adiposity in the 
gluteo-femoral or hip region has been shown in non-Asian cohorts to exert a protective effect 
on cardiovascular risk factors.  Therefore, we examined the independent association of hip 
circumference with incident metabolic risk factors in Chinese.  We found hip circumference, 
when adjusted for waist or BMI, attenuated the risk of incident metabolic risk factors in both 
men and women.  A larger hip circumference was significantly associated with a lower 
incidence of low HDL-C, elevated triglycerides and multiple metabolic abnormalities in 
Women when controlling for waist and BMI.  In men, none of the associations were 
significant.  Our findings were similar to those observed in non-Asian populations.  
Specifically, the weaker associations of hip circumference with blood pressure and the 
stronger associations observed for women then for men.  Adiposity in the lower trunk region 
has been suggested to be the component of hip responsible for the observed protective effect 
for metabolic risk factors.   It is therefore quite noteworthy that we were able to detect 
protective associations of hip with metabolic risk factors in such a lean sample.  It would be 
worthwhile to re-examine the association in a more overweight sample of Chinese. 
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In conclusion, Chinese tend to experience metabolic risk factors associated with 
adiposity, even at very low levels of BMI. This is quite concerning considering the Chinese 
are experiencing rapid increases in the proportion of overweight and obese adults within 
China.  CVD, which is currently the leading cause of death in China, will most likely afflict a 
greater proportion of the population as obesity levels increase.  This work was intended to 
provide a better understanding of the association of anthropometric measures with 
cardiovascular outcomes in multi-ethnic populations and we hope it may be used to support 
future research as well as initiatives designed to promote maintenance of a healthy weight, 
prevent the onset of excess weight and promote weight loss among those who are already 
overweight or obese in an effort to reduce cardiovascular risk among populations.  
B. Strengths 
The CARDIA, ARIC and PRC datasets provide some of the best, if not the best, data 
currently available, given our goals.  The datasets are similar in design and provide data from 
diverse populations and age ranges. The Collaborative Studies Coordinating Center (CSCC) 
at the University of North Carolina, Chapel Hill served as the coordinating center for both the 
PRC and ARIC studies. They provided training manuals and protocols for data collection and 
were responsible for data processing and review for both studies. The University of Alabama 
at Birmingham served as the coordinating center for the CARDIA study. The CARDIA 
Coordinating Center, and the CARDIA Quality Control Committee monitored data collection 
throughout the study and all data collection technicians were centrally trained and certified. 
Many of the relevant variables for the work proposed here were collected using identical 
protocols in CARDIA, ARIC and PRC. 
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The questions evaluated by this work are novel and provide new insights into aging 
and obesity in ethnically diverse populations. 
C. Limitations 
There are limitations to this work.  Namely, several factors that influence blood 
pressure are hard to measure (psychosocial factors); some of the variables are not equivalent 
across ethnic groups (education level); potential bias may be introduced by variable treatment 
rates across ethnic groups; the overlay of ethnicity and social factors, geography and 
nationality cannot be separated; populations studies are from different countries; and lastly 
we did not have measures of diet, parental and offspring hypertension onset, or comparable 
measures of physical activity across ethnic groups. 
D. Conclusion 
These results provide novel insights into obesity in Chinese.  It would be worthy to 
replicate Aim 1 by using a sample of Chinese Americans.  However, as this data does not 
currently exist, it would involve data collection which could take many years.  The PRC 
baseline data were collected in 1983-84 and the prevalence of overweight and obesity in 
China during this time was lower than more recent estimates.  Therefore, Aims 2 and 3, 
which focus exclusively on Chinese, should be replicated in more overweight populations 
within China and validated measures of parental hypertension status and age of parental 
hypertension onset should be collected.  Our research provides a significant contribution to 
the literature and given the current availability of Chinese cohort data, these findings may be 
the most appropriate. 
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APPENDICES  
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Appendix B: Additional outcomes examined for Chapter 6 analyses 
The following table includes the crude prevalence and cumulative incidence for 
additional outcomes we explored for “The Association of Hip Circumference with Incident 
Metabolic Risk Factors in Chinese, the People’s Republic of China Study” (Chapter 6).  
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Table B.1. Crude baseline prevalence and cumulative incidence for metabolic risk factors 
 MALES FEMALES 
  Baseline prevalence  Cumulative Incidence Baseline prevalence  Cumulative Incidence 
 
# 
cases/sample  %   # cases/sample  %   # cases/sample  %   # cases/sample  %   
SBP>140 59/1144 5.2%   160/1085 14.7%   107/1776 6.0%   224/1445 15.5% 
 DBP>90 68/1144 5.9%   151/1076 14.0%   89/1776 5.0%   140/1687 8.3% 
 Elevated BP (BP>130/85) 197/1144 17.2%   286/947 30.2%   270/1776 15.2%   356/1506 23.6% 
 Hypertension 99/1144 8.7%   203/1045 19.4%   149/1776 8.4%   241/1627 14.8% 
Elevated fasting glucose 
>100mg/dl 86/1144 7.5%   91/1058 8.6%   171/1776 9.6%   210/1605 13.1% 
Elevated fasting glucose 
>110mg/dl 39/1144 3.4%   40/1105 3.6%   67/1776 3.8%   93/1709 5.4% 
Diabetes 13/1144 1.1%   26/1131 2.3%   24/1776 1.4%   39/1752 2.2% 
Total Cholesterol > 200 mg/dl 392/1144 34.3%   162/752 21.5%   564/1776 31.8%   298/1212 24.6% 
Total Cholesterol > 240 mg/dl 101/1144 8.8%   72/1043 6.9%   146/1776 8.2%   131/1630 8.0% 
LDL Cholesterol > 160 mg/dl 116/1091 10.6%   60/975 6.2%   135/1744 7.7%   147/1609 9.1% 
HDL Cholesterol < 40 mg/dl  172/1144 15.0%   129/972 13.3%   610/1776 34.3%   383/1166 32.8% 
Triglycerides > 150 mg/dl 253/1144 22.1%   141/891 15.8%   424/1776 23.9%   150/1352 11.1% 
Triglycerides > 200 mg/dl 137/1144 12.0%   90/1007 8.9%   241/1776 13.6%   76/1535 5.0% 
Multiple metabolic abnormalities: 
>3 above  criteria 27/1144 2.4%   68/1117 6.1%   89/1776 5.0%   149/1687 8.8% 
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